BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Fang YL, Chen H, Wang CL, Liang L. Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From “two hit theory” to “multiple hit model”. World J Gastroenterol 2018; 24(27): 2974-2983 [PMID: 30038464 DOI: 10.3748/wjg.v24.i27.2974]
URL: https://www.wjgnet.com/1007-9327/full/v24/i27/2974.htm
(339) (387) (0) (0) (30) (1) (32505) (350)
Number Citing Articles
1
梓璇 王. Research Progress on the Treatment of Non-Alcoholic Fatty Liver Disease with Mediterranean Diet. Advances in Clinical Medicine 2025; 15(05) doi: 10.12677/acm.2025.1551598
2
Liudmyla K. Parkhomenko, Larysa A. Strashok, Margaryta A. Khomenko. THE ROLE OF ZONULIN IN THE DEVELOPMENT OF LIVER FIBROSIS IN OBESE ADOLESCENTS. Wiadomości Lekarskie 2021; 74(1) doi: 10.36740/WLek202101115
3
Chander K. Negi, Sabbir Khan, Hubert Dirven, Lola Bajard, Luděk Bláha. Flame Retardants-Mediated Interferon Signaling in the Pathogenesis of Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2021; 22(8) doi: 10.3390/ijms22084282
4
Shuang Liang, Mingli Li, Jiali Lin, Shengzhu Huang, Yulan Bai, Zefeng Chen, Xinyang Long, Yuanfan Li, Qianqian Luo, Zheng Wen, Zengnan Mo. Association between predicted body composition and metabolic-associated fatty liver disease: a case-control study in a Chinese population. Frontiers in Medicine 2026; 13 doi: 10.3389/fmed.2026.1750432
5
Hai-Ling Peng, Li-Ni Liu, De-Liang Liu, Yu-Yong Tan. Depression and non-alcoholic fatty liver disease: Association and potential mechanisms. World Chinese Journal of Digestology 2022; 30(7) doi: 10.11569/wcjd.v30.i7.295
6
Qiang Teng, Huihui Lv, Lingling Peng, Zhongyue Ren, Jiahui Chen, Lixue Ma, Hua Wei, Cuixiang Wan. Lactiplantibacillus plantarum ZDY2013 Inhibits the Development of Non-Alcoholic Fatty Liver Disease by Regulating the Intestinal Microbiota and Modulating the PI3K/Akt Pathway. Nutrients 2024; 16(7) doi: 10.3390/nu16070958
7
Kavita Jadhav, Taylor S. Cohen. Can You Trust Your Gut? Implicating a Disrupted Intestinal Microbiome in the Progression of NAFLD/NASH. Frontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.592157
8
Xingxing Yuan, Liuxin Yang, Tinting Gao, Jiawei Gao, Bingyu Wang, Chengxiang Liu, Wei Yuan. YinChen WuLing powder attenuates non-alcoholic steatohepatitis through the inhibition of the SHP2/PI3K/NLRP3 pathway. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1423903
9
Laura G. Draijer, Denise Froon‐Torenstra, Michel van Weeghel, Frédéric M. Vaz, Anneloes E. Bohte, Adriaan G. Holleboom, Marc A. Benninga, Bart G.P. Koot. Lipidomics in Nonalcoholic Fatty Liver Disease. Journal of Pediatric Gastroenterology and Nutrition 2020; 71(4) doi: 10.1097/MPG.0000000000002875
10
Simona Riccio, Rosa Melone, Caterina Vitulano, Pierfrancesco Guida, Ivan Maddaluno, Stefano Guarino, Pierluigi Marzuillo, Emanuele Miraglia del Giudice, Anna Di Sessa. Advances in pediatric non-alcoholic fatty liver disease: From genetics to lipidomics. World Journal of Clinical Pediatrics 2022; 11(3): 221-238 doi: 10.5409/wjcp.v11.i3.221
11
Zhaolin Sun, Yuhua Wei, Yuchen Xu, Jianwei Jiao, Xiuying Duan. The use of traditional Chinese medicine in the treatment of non-alcoholic fatty liver disease: A review. Pharmacological Research - Modern Chinese Medicine 2024; 12 doi: 10.1016/j.prmcm.2024.100475
12
Xianmin Dai, Jiayi Feng, Yi Chen, Si Huang, Xiaofei Shi, Xia Liu, Yang Sun. Traditional Chinese Medicine in nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives. Chinese Medicine 2021; 16(1) doi: 10.1186/s13020-021-00469-4
13
Taís Menezes do Moinho, Sandro Leão Matos, Carla R. O. Carvalho. A comprehensive review on phytochemicals for fatty liver: are they potential adjuvants?. Journal of Molecular Medicine 2022; 100(3) doi: 10.1007/s00109-021-02170-3
14
Mykhailo Buchynskyi, Valentyn Oksenych, Iryna Kamyshna, Sandor G. Vari, Aleksandr Kamyshnyi. Genetic Predictors of Comorbid Course of COVID-19 and MAFLD: A Comprehensive Analysis. Viruses 2023; 15(8) doi: 10.3390/v15081724
15
Mahshad Paziraee, Habib Asgharpour, Asra Askari, Reza Rezaei Shirazi, Neda Aghaei Bahman Beglo. The effect of running and starvation interventions on atherogenic index and Xbp1 gene expression in the endoplasmic reticulum of liver in non-alcoholic fatty liver rats. Medical Laboratory Journal 2024; 18(6) doi: 10.66224/mlj.18.6.19
16
Claudia Theys, Tineke Vanderhaeghen, Evelien Van Dijck, Cedric Peleman, Anne Scheepers, Joe Ibrahim, Ligia Mateiu, Steven Timmermans, Tom Vanden Berghe, Sven M. Francque, Wim Van Hul, Claude Libert, Wim Vanden Berghe. Loss of PPARα function promotes epigenetic dysregulation of lipid homeostasis driving ferroptosis and pyroptosis lipotoxicity in metabolic dysfunction associated Steatotic liver disease (MASLD). Frontiers in Molecular Medicine 2024; 3 doi: 10.3389/fmmed.2023.1283170
17
Guillermo Santos-Sánchez, Ivan Cruz-Chamorro. Plant-derived bioactive peptides and protein hydrolysates for managing MAFLD: A systematic review of in vivo effects.. Food Chemistry 2025; 481 doi: 10.1016/j.foodchem.2025.143956
18
Sean Backer, Deepesh Khanna. The Lasting Effects of COVID-19 on the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Cureus 2023;  doi: 10.7759/cureus.45231
19
Yana Sandlers, Rohan R. Shah, Ryan W. Pearce, Jaividhya Dasarathy, Arthur J. McCullough, Srinivasan Dasarathy. Plasma Krebs Cycle Intermediates in Nonalcoholic Fatty Liver Disease. Journal of Clinical Medicine 2020; 9(2) doi: 10.3390/jcm9020314
20
Adiya E. Otumala, Dominick J. Hellen, C. Alessandra Luna, Priscilla Delgado, Anjana Dissanayaka, Chidozie Ugwumadu, Oluwamayokun Oshinowo, Md. Mydul Islam, Luyao Shen, Saul J. Karpen, David R. Myers. Opportunities and considerations for studying liver disease with microphysiological systems on a chip. Lab on a Chip 2023; 23(13) doi: 10.1039/D2LC00940D
21
Yuan Xiaowu, Dong Jian, Wen Yizhu, Ma Ting, Tong Jin, Wei Juan, Wang Sirui, Wang Jinli, He Yuchen, Zhao Huan, Cheng Yuhang, Li Jun. Development and validation of a non-invasive prediction model for identifying high-risk children with metabolic dysfunction-associated fatty liver disease. Frontiers in Pediatrics 2025; 13 doi: 10.3389/fped.2025.1625864
22
Lijun Luo, Yongchun Chang, Li Sheng. Gut-liver axis in the progression of nonalcoholic fatty liver disease: From the microbial derivatives-centered perspective. Life Sciences 2023; 321 doi: 10.1016/j.lfs.2023.121614
23
V. I. Didenko, I. A. Klenina, О. M. Tatarchuk, O. I. Hrabovska, O. P. Petishko. Specificities of lipotoxicity of free fatty acids and cytokine profile in patients with chronic diffuse liver diseases . Regulatory Mechanisms in Biosystems 2021; 13(1) doi: 10.15421/022201
24
Zhi Huang, Rong-Rong Zhou. Mechanism for FXR to regulate bile acid and glycolipid metabolism to improve NAFLD. World Chinese Journal of Digestology 2023; 31(19) doi: 10.11569/wcjd.v31.i19.797
25
V. T. Ivashkin, O. M. Drapkina, M. V. Maevskaya, K. L. Raikhelson, S. V. Okovityi, M. S. Zharkova, V. R. Grechishnikova, D. I. Abdulganieva, S. A. Alekseenko, M. D. Ardatskaya, I. G. Bakulin, N. V. Bakulina, P. O. Bogomolov, V. V. Breder, E. V. Vinnitskaya, N. I. Geyvandova, E. V. Golovanova, V. B. Grinevich, V. L. Doshchitsin, E. N. Dudinskaya, E. V. Ershova, K. B. Kodzoeva, I. V. Kozlova, K. A. Komshilova, Yu. V. Konev, N. V. Korochanskaya, Yu. V. Kotovskaya, Yu. A. Kravchuk, I. D. Loranskaya, I. V. Maev, A. I. Martynov, S. N. Mekhtiev, E. E. Mishina, M. Yu. Nadinskaia, I. G. Nikitin, M. F. Osipenko, O. D. Ostroumova, Ch. S. Pavlov, N. V. Pogosova, V. G. Radchenko, G. E. Roytberg, R. G. Saifutdinov, A. A. Samsonov, P. V. Seliverstov, S. I. Sitkin, L. V. Tarasova, A. I. Tarzimanova, O. N. Tkacheva, E. I. Tkachenko, E. A. Troshina, S. V. Turkina, Yu. P. Uspenskiy, Yu. A. Fominykh, O. V. Khlynova, Yu. V. Tsyganova, M. Sh. Shamkhalova, O. O. Sharkhun, M. V. Shestakova. Clinical Guidelines of the Russian Society for the Study of the Liver, Russian Gastroenterological Association, Russian Society for the Prevention of Non-Communicable Diseases, Russian Association of Endocrinologists, Russian Scientific Medical Society of Therapists, National Society of Preventive Cardiology, Russian Association of Gerontologists and Geriatricians on Non-Alcoholic Fatty Liver Disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2025; 35(1) doi: 10.22416/1382-4376-2025-35-1-94-152
26
Qi Shao, Yiping Wu, Jing Ji, Tian Xu, Qiaoyu Yu, Chongyang Ma, Xuejing Liao, Fafeng Cheng, Xueqian Wang. Interaction Mechanisms Between Major Depressive Disorder and Non-alcoholic Fatty Liver Disease. Frontiers in Psychiatry 2021; 12 doi: 10.3389/fpsyt.2021.711835
27
Nana Wang, Yuan Huo, Xue Gao, Yuting Li, Fangru Cheng, Zengli Zhang. Lead exposure exacerbates liver injury in high-fat diet-fed mice by disrupting the gut microbiota and related metabolites. Food & Function 2024; 15(6) doi: 10.1039/D3FO05148J
28
Wen-Chih Huang, Pei-Ni Lee, Wan-Ju Yeh, Wen-Chi Wu, Hsin-Yu Shih, Yi-Jen Chen, Hsin-Yi Yang. Effects of Blue Light Exposure on Hepatic Inflammation and Gut Microbiota in Mice Consuming a High-Fat, High-Fructose Diet. Nutrients 2026; 18(1) doi: 10.3390/nu18010164
29
Yu Mou, Yao Tang, Xiuyan Zheng, Xiang Liu, Xuemei Wu, Hongji Wang, Jie Zeng, Qing Rao, Yaacov Ben-David, Yanmei Li, Lei Huang. Unraveling the molecular mechanisms of Fufangduzhong formula in alleviating high-fat diet-induced non-alcoholic fatty liver disease in mice. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1542143
30
Eda Kaya, Yusuf Yilmaz. Obesity and Diabetes. 2020;  doi: 10.1007/978-3-030-53370-0_24
31
Liangying Ye, Dan Zhao, Yangzhi Xu, Jiaen Lin, Jiahui Xu, Kunyuan Wang, Zhanhui Ye, Yufeng Luo, Shiming Liu, Hui Yang. LncRNA-Gm9795 promotes inflammation in non-alcoholic steatohepatitis via NF-$$\kappa {}$$B/JNK pathway by endoplasmic reticulum stress. Journal of Translational Medicine 2021; 19(1) doi: 10.1186/s12967-021-02769-7
32
Jiayao Feng, Shuting Qiu, Shipeng Zhou, Yue Tan, Yan Bai, Hua Cao, Jiao Guo, Zhengquan Su. mTOR: A Potential New Target in Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2022; 23(16) doi: 10.3390/ijms23169196
33
Xuecheng Li, Yi Lu, Xiaoshuang Liang, Xiaofei Zhou, Dirui Li, Zan Zhang, Yunchao Niu, Shuaishuai Liu, Ling Ye, Rufeng Zhang, Gianfranco D. Alpini. A new NASH model in aged mice with rapid progression of steatohepatitis and fibrosis. PLOS ONE 2023; 18(5) doi: 10.1371/journal.pone.0286257
34
Kévin Bernal, Charbel Touma, Béatrice Le-Grand, Sophie Rose, Selenay Degerli, Valentine Genêt, Dominique Lagadic-Gossmann, Xavier Coumoul, Corinne Martin-Chouly, Sophie Langouët, Etienne B Blanc. Assessment of endocrine disruptor impacts on lipid metabolism in a fatty acid-supplemented HepaRG human hepatic cell line. Chemosphere 2024; 349 doi: 10.1016/j.chemosphere.2023.140883
35
Qian-Long Wu, Shu-Xin Zeng, Jia-Ying Peng, Yi Yuan, Zhi Zhu, Zi-Chun Xie, Ze-Hong Huang, Jia-Shuan Huang, Jian-Mei Lai, Jin-an Chen, Min-Hua Lin. Advances in metformin for the treatment of non-alcoholic fatty liver disease in children. Expert Review of Gastroenterology & Hepatology 2022; 16(9) doi: 10.1080/17474124.2022.2118112
36
Ghazaleh Pourali, Zeinab S. Hosseini, Mina Maftooh, Elham Nazari, Majid Khazaei, Mohammadreza Nassiri, Seyed M. Hassanian, Majid Ghayour-Mobarhan, Gordon A. Ferns, Mohammad A. Kiani, Amir Avan. Therapeutic Potential of Herbal Medicine against Non-alcoholic Fatty Liver Disease. Current Drug Targets 2023; 24(4) doi: 10.2174/1389450124666230113150116
37
Truc Thanh Nguyen, Huong Tu Lam, Thong Duy Vo. Association Between the GGT/HDL-C Ratio and Ultrasonography-Defined NAFLD in Vietnamese Adults: A Cross-Sectional Study. Journal of Personalized Medicine 2026; 16(9) doi: 10.3390/jpm16090441
38
Hae-Jin Ko, Sarah Woo, Junhee Han, Yoon Myung Kim, Hyun Jung Lim, Min-Jeong Kim, Yong Soon Park, Kyung Hee Park. Which obesity index is the most useful marker for predicting hepatic steatosis in children and adolescents with obesity? A cross-sectional study using quantitative magnetic resonance imaging. Obesity Research & Clinical Practice 2023; 17(4) doi: 10.1016/j.orcp.2023.05.013
39
Mingzhe Zhu, Meng Li, Wenjun Zhou, Yang Yang, Fenghua Li, Li Zhang, Guang Ji. Qianggan extract improved nonalcoholic steatohepatitis by modulating lncRNA/circRNA immune ceRNA networks. BMC Complementary and Alternative Medicine 2019; 19(1) doi: 10.1186/s12906-019-2577-6
40
Resthie R. Putri. The evolving landscape of pediatric obesity and metabolic dysfunction-associated steatotic liver disease. Frontiers in Pediatrics 2025; 13 doi: 10.3389/fped.2025.1675713
41
Dalia Dop, Vlad Pădureanu, Rodica Pădureanu, Carmen Elena Niculescu, Ștefan Adrian Niculescu, Iulia Rahela Marcu. Diagnosis and Management of Pediatric Non-Alcoholic Fatty Liver Disease: An Overview. Metabolites 2025; 15(12) doi: 10.3390/metabo15120792
42
Zhibin Yan, Xiaokang Miao, Bangzhi Zhang, Junqiu Xie. p53 as a double-edged sword in the progression of non-alcoholic fatty liver disease. Life Sciences 2018; 215 doi: 10.1016/j.lfs.2018.10.051
43
Yiyuan Zheng, Dan Fang, Chaoyuan Huang, Lina Zhao, Liming Gan, Youlan Chen, Fengbin Liu. Gentiana scabra Restrains Hepatic Pro-Inflammatory Macrophages to Ameliorate Non-Alcoholic Fatty Liver Disease. Frontiers in Pharmacology 2022; 12 doi: 10.3389/fphar.2021.816032
44
Ruwen Yang, Jingyu Shang, Yaru Zhou, Weiwei Liu, Yaozhou Tian, Hongtao Shang. Effects of probiotics on nonalcoholic fatty liver disease: a systematic review and meta-analysis. Expert Review of Gastroenterology & Hepatology 2021; 15(12) doi: 10.1080/17474124.2022.2016391
45
Zhaonian Li, Mengfei Li, Yongzhan Bao, Xiao Wang, Wanyu Shi. Integrating network pharmacology and in vivo evaluation reveals chicory (Cichorium intybus L.) extract activates autophagy to alleviate fatty liver hemorrhagic syndrome in laying hens. Poultry Science 2026; 105(10) doi: 10.1016/j.psj.2026.107295
46
Eliut Pérez Sánchez, Adriana Corona-Pérez, Omar Arroyo-Helguera, Ida Soto Rodríguez, Senobia Rosalía Cruz Lumbreras, Jorge Rodríguez-Antolín, Estela Cuevas Romero, Leticia Nicolás-Toledo. Chronic unpredictable mild stress increases serum aldosterone without affecting corticosterone levels and induces hepatic steatosis and renal injury in young adult male rats. Journal of Molecular Histology 2024; 55(3) doi: 10.1007/s10735-024-10188-3
47
Mengting Chen, Pengfei Hou, Min Zhou, Qingbo Ren, Xiaolan Wang, Li Huang, Suocheng Hui, Long Yi, Mantian Mi. Resveratrol attenuates high-fat diet-induced non-alcoholic steatohepatitis by maintaining gut barrier integrity and inhibiting gut inflammation through regulation of the endocannabinoid system. Clinical Nutrition 2020; 39(4) doi: 10.1016/j.clnu.2019.05.020
48
Jerad H. Dumolt, Min Ma, Joyce Mathew, Mulchand S. Patel, Todd C. Rideout. Gestational hypercholesterolemia alters fetal hepatic lipid metabolism and microRNA expression in Apo-E-deficient mice. American Journal of Physiology-Endocrinology and Metabolism 2019; 317(5) doi: 10.1152/ajpendo.00138.2019
49
Zhuo-yuan Wang, Si-ting Gao, Xiao-jun Gou, Fu-rong Qiu, Qin Feng. IL-1 receptor-associated kinase family proteins: An overview of their role in liver disease. European Journal of Pharmacology 2024; 978 doi: 10.1016/j.ejphar.2024.176773
50
Y Saigo, T Sasase, M Tohma, K Uno, Y Shinozaki, T Maekawa, R Sano, K Miyajima, T Ohta. High-Cholesterol Diet in Combination With Hydroxypropyl-β Cyclodextrin Induces NASH-Like Disorders in the Liver of Rats. Physiological Research 2023; 72(3) doi: 10.33549/physiolres.934981
51
Ayumi Karasawa, Mio Takimoto, Yuri Sakamaki, Momoko Shoubudani, Kanami Ohshima, Erika Hara, Bai Yidan, Mengyuan Luo, Mai Todoroki, Mio Kobayashi, Ma Suzanneth G. Lola, Xinyu Zou, Sha Jiang, Tetsuhito Kigata, Makoto Shibutani, Toshinori Yoshida. Autophagy suppression is associated with enhanced preneoplastic hepatocellular lesions in rats fed a lard-containing high-fat diet. Food and Chemical Toxicology 2026; 217 doi: 10.1016/j.fct.2026.116334
52
Melisa Kozaczek, Walter Bottje, Byungwhi Kong, Diyana Albataineh, Reza Hakkak. A Comparison of Short- and Long-Term Soy Protein Isolate Intake and Its Ability to Reduce Liver Steatosis in Obese Zucker Rats Through Modifications of Genes Involved in Inflammation and Lipid Transport. Journal of Medicinal Food 2021; 24(9) doi: 10.1089/jmf.2020.0180
53
Siqi Liu, Penglong Chen, Yayi Li, Zhisen Pan, Can Zhang, Anquan Li, Chongyan Huang, Hongxuan Zheng, Like Chen, Chuangpeng Shen. Bupleurum chinense ameliorates metabolic-associated fatty liver disease by modulating Sirtuin 6. Phytomedicine 2026; 153 doi: 10.1016/j.phymed.2026.157905
54
Rubén Peña-Vélez, Nayely Garibay-Nieto, Manuel Cal-y-Mayor-Villalobos, Estibalitz Laresgoiti-Servitje, Karen Pedraza-Escudero, María del Carmen García-Blanco, Omar Alfonso Heredia-Nieto, Eréndira Villanueva-Ortega. Association between neck circumference and non-alcoholic fatty liver disease in Mexican children and adolescents with obesity. Journal of Pediatric Endocrinology and Metabolism 2020; 33(2) doi: 10.1515/jpem-2019-0204
55
Mario Bartiromo, Michele Nardolillo, Serena Ferrara, Giuseppina Russo, Emanuele Miraglia Del Giudice, Anna Di Sessa. The challenging role of micro-RNAs in non-alcoholic fatty liver disease in children with obesity: is it time for a new era?. Expert Review of Gastroenterology & Hepatology 2023; 17(8) doi: 10.1080/17474124.2023.2242245
56
Xiao-Qian Shan, Lan Zhao. Enhancing the functionality of mesenchymal stem cells: An attractive treatment strategy for metabolic dysfunction-associated steatotic liver disease?. World Journal of Stem Cells 2024; 16(10): 854-859 doi: 10.4252/wjsc.v16.i10.854
57
Jeanette Irene Christiene Manoppo, Vivekenanda Pateda, Cindy Prayogo, Fima L. F. G. Langi, Fahrul Nurkolis, Apollinaire Tsopmo. Relationships of 25-hydroxyvitamin D levels and non-alcoholic fatty liver disease in obese children: A possible strategy to promote early screening of NAFLD. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.1025396
58
Sana Raza, Sangam Rajak, Rajani Singh, Jin Zhou, Rohit A Sinha, Amit Goel. Cell-type specific role of autophagy in the liver and its implications in non-alcoholic fatty liver disease. World Journal of Hepatology 2023; 15(12): 1272-1283 doi: 10.4254/wjh.v15.i12.1272
59
Yuxuan Zhang, Jiali Zhou, Lan Yang, Hang Xiao, Dongbo Liu, Xincong Kang. Ganoderma lucidum Spore Powder Alleviates Metabolic-Associated Fatty Liver Disease by Improving Lipid Accumulation and Oxidative Stress via Autophagy. Antioxidants 2024; 13(12) doi: 10.3390/antiox13121501
60
Yong Tae Park, Eui Yup Chung, Chang Ho Chae, Young Hoon Lee. Association between serum perfluoroalkyl substances concentrations and non-alcoholic fatty liver disease among Korean adults: a cross-sectional study using the National Environmental Health Survey cycle 4. Annals of Occupational and Environmental Medicine 2024; 36(1) doi: 10.35371/aoem.2024.36.e10
61
Timothy P. LaBranche, Anna K. Kopec, Srinivasa R. Mantena, Brett D. Hollingshead, Andrew W. Harrington, Zachary S. Stewart, Yutian Zhan, Kyle D. Hayes, Laurence O. Whiteley, Andrew D. Burdick, John W. Davis. Zucker Lean Rats With Hepatic Steatosis Recapitulate Asymptomatic Metabolic Syndrome and Exhibit Greater Sensitivity to Drug-Induced Liver Injury Compared With Standard Nonclinical Sprague-Dawley Rat Model. Toxicologic Pathology 2020; 48(8) doi: 10.1177/0192623320968716
62
Mariana M. Ramírez-Mejía, Xingshun Qi, Ludovico Abenavoli, Manuel Romero-Gómez, Mohammed Eslam, Nahum Méndez-Sánchez. Metabolic dysfunction: The silenced connection with fatty liver disease. Annals of Hepatology 2023; 28(6) doi: 10.1016/j.aohep.2023.101138
63
Hongying Yang, Dongyun Wei, Yao Zhang, Wenxuan Jian. Huangqin-Huanglian Decoction Protects Liver against Non-alcoholic Fatty Liver Disease in High Fat-diet Mice. Endocrine, Metabolic & Immune Disorders - Drug Targets 2024; 24(6) doi: 10.2174/0118715303257018230927182802
64
Devaraj Ezhilarasan. Mechanism of Semaglutide in MASLD Treatment: Where Is the Master Key?. Journal of Gastroenterology and Hepatology 2025; 40(9) doi: 10.1111/jgh.17037
65
Shiqi Hao, Liang Ming, Yafei Li, Haodi Lv, Lin Li, Tuyatsetseg Jambal, Rimutu Ji. Modulatory effect of camel milk on intestinal microbiota of mice with non-alcoholic fatty liver disease. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.1072133
66
Xiaojian Zhang, Yanbin Cheng, Qingyu Wei, Lixuan Sang, Quansheng Li. Exercise and Berberine Intervention Ameliorate High-Fat Diet-Induced MAFLD by Regulating Gut Microbiota and Hepatic Fatty Acid Beta-Oxidation. Journal of Inflammation Research 2025;  doi: 10.2147/JIR.S498782
67
Zixuan Zhang, Jiaxi Shi, Fuxuan Liu, Jing Zhou, Qi Shen, Xuguang Shi. Targeting AGE-RAGE Signaling Pathway with Hujin Decoction Ameliorates MAFLD in HepG2 Cells. Diabetes, Metabolic Syndrome and Obesity 2025;  doi: 10.2147/DMSO.S506350
68
Marta Flisiak-Jackiewicz, Anna Bobrus-Chociej, Natalia Wasilewska, Dariusz Marek Lebensztejn. From Nonalcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—New Terminology in Pediatric Patients as a Step in Good Scientific Direction?. Journal of Clinical Medicine 2021; 10(5) doi: 10.3390/jcm10050924
69
Xixi Fang, Chenhao Xu, Jun Lu, Runzhou Zhuang, Xiao Xu, Xuyong Wei. Lean Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Wolf in Sheep's Clothing. Cell Biochemistry and Function 2025; 43(11) doi: 10.1002/cbf.70136
70
Keishi Kisoh, Go Sugahara, Yuko Ogawa, Suzue Furukawa, Yuji Ishida, Takeshi Okanoue, Michinori Kohara, Chise Tateno. Estimating Drug Efficacy with a Diet-Induced NASH Model in Chimeric Mice with Humanized Livers. Biomedicines 2021; 9(11) doi: 10.3390/biomedicines9111647
71
V. T. Ivashkin, M. V. Maevskaya, M. S. Zharkova, Yu. V. Kotovskaya, O. N. Tkacheva, E. A. Troshina, M. V. Shestakova, I. V. Maev, V. V. Breder, N. I. Gheivandova, V. L. Doshchitsin, E. N. Dudinskaya, E. V. Ershova, Kh. B. Kodzoeva, K. A. Komshilova, N. V. Korochanskaya, A. Yu. Mayorov, E. E. Mishina, M. Yu. Nadinskaya, I. G. Nikitin, N. V. Pogosova, A. I. Tarzimanova, M. Sh. Shamkhalova. Clinical Practice Guidelines of the Russian Scientific Liver Society, Russian Gastroenterological Association, Russian Association of Endocrinologists, Russian Association of Gerontologists and Geriatricians and National Society for Preventive Cardiology on Diagnosis and Treatment of Non-Alcoholic Liver Disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2022; 32(4) doi: 10.22416/1382-4376-2022-32-4-104-140
72
Fan Yang, Mengyuan Hu, Haoyang Zhang, Xiaowei Zheng, Limei Chen, Lihong Zhu, Le Zhang. Protocol for a Longitudinal Cohort Study to Understand Characteristics and Risk Factors Underlying Vibration-Controlled Transient Elastography-Diagnosed Metabolic Dysfunction-Associated Fatty Liver Disease Children. Diabetes, Metabolic Syndrome and Obesity 2024;  doi: 10.2147/DMSO.S492809
73
Jing-Jie Wang, Yi-Tong Zhang, Yu Jen Tseng, Jun Zhang. miR-222 targets ACOX1, promotes triglyceride accumulation in hepatocytes. Hepatobiliary & Pancreatic Diseases International 2019; 18(4) doi: 10.1016/j.hbpd.2019.05.002
74
Xushan Yang, Yudi Deng, Yali Tu, Dongliang Feng, Wenzhen Liao. Nobiletin mitigates NAFLD via lipophagy and inflammation. Food & Function 2022; 13(19) doi: 10.1039/D2FO01682F
75
Dong-xuan Zheng, Yu Wang, Qiang Hou, Li-mei Wen, Jiang-yun Liu, Qiang Yin, Hai-long Yin, Zao-ling Liu, Jun-ping Hu, Jian-hua Yang. Yanxiao Di’naer decoction attenuates metabolic dysfunction-associated steatohepatitis through the regulation of gut microbiota and the metabolism of bile acid. Journal of Ethnopharmacology 2026; 364 doi: 10.1016/j.jep.2026.121486
76
Antonella Mosca, Luca Della Volpe, Maria Rita Sartorelli, Donatella Comparcola, Silvio Veraldi, Anna Alisi, Giuseppe Maggiore. Metabolic Associated Fatty Liver Disease in Children and Adolescents: Mechanisms of a Silent Epidemic and Therapeutic Options. Current Pediatric Reviews 2024; 20(3) doi: 10.2174/1573396319666230403121805
77
Fangfang Chen, Hanna Friederike Willenbockel, Thekla Cordes. Mapping the Metabolic Niche of Citrate Metabolism and SLC13A5. Metabolites 2023; 13(3) doi: 10.3390/metabo13030331
78
. 2024;  doi: 10.70675/5d147ab4zad37z4f6bzac51z32a08efeaa51
79
Gary Huang, Daniel F. Wallace, Elizabeth E. Powell, Tony Rahman, Paul J. Clark, V. Nathan Subramaniam. Gene Variants Implicated in Steatotic Liver Disease: Opportunities for Diagnostics and Therapeutics. Biomedicines 2023; 11(10) doi: 10.3390/biomedicines11102809
80
Zhe-Wen Qin, Qian-Nan Ren, Hong-Xi Zhang, Ya-Ru Liu, Ke Huang, Wei Wu, Guan-Ping Dong, Yan Ni, Jun-Fen Fu. Development and validation of a novel non-invasive test for diagnosing nonalcoholic fatty liver disease in Chinese children. World Journal of Pediatrics 2024; 20(4) doi: 10.1007/s12519-023-00704-y
81
. 2023;  doi: 10.70675/0aa0727cz8dd2z47e4z90e9zbdc6fc7266cd
82
Paola Mogna-Peláez, Ana Romo-Hualde, José I. Riezu-Boj, Fermin I. Milagro, David Muñoz-Prieto, José I. Herrero, Mariana Elorz, Alberto Benito-Boillos, J. Ignacio Monreal, Josep A. Tur, Alfredo Martínez, Itziar Abete, M. Angeles Zulet. Isoliquiritigenin in combination with visceral adipose tissue and related markers as a predictive tool for nonalcoholic fatty liver disease. Journal of Physiology and Biochemistry 2024; 80(3) doi: 10.1007/s13105-023-00998-6
83
Runbin Sun, Dan Xu, Qingli Wei, Bangling Zhang, Jiye Aa, Guangji Wang, Yuan Xie. Silybin ameliorates hepatic lipid accumulation and modulates global metabolism in an NAFLD mouse model. Biomedicine & Pharmacotherapy 2020; 123 doi: 10.1016/j.biopha.2019.109721
84
Magdalena A. Maj, Douglas G. Burrin, Rodrigo Manjarín. Decreased FXR Agonism in the Bile Acid Pool Is Associated with Impaired FXR Signaling in a Pig Model of Pediatric NAFLD. Biomedicines 2023; 11(12) doi: 10.3390/biomedicines11123303
85
Yuqiao Liu, Yue Fan, Jibin Liu, Xiyang Liu, Xiuyan Li, Jingqing Hu. Application and mechanism of Chinese herb medicine in the treatment of non-alcoholic fatty liver disease. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1499602
86
Nannan Sun, Chuangpeng Shen, Lei Zhang, Xiaojie Wu, Yuanyuan Yu, Xiaoying Yang, Chen Yang, Chong Zhong, Zhao Gao, Wei Miao, Zehong Yang, Weihang Gao, Ling Hu, Kevin Williams, Changhui Liu, Yongsheng Chang, Yong Gao. Hepatic Krüppel-like factor 16 (KLF16) targets PPARα to improve steatohepatitis and insulin resistance. Gut 2021; 70(11) doi: 10.1136/gutjnl-2020-321774
87
J. Carretero-Gómez, F.J. Carrasco-Sánchez, J.M. Fernández-Rodríguez, P. Casado-Escribano, J.P. Miramontes-González, J.M. Seguí-Ripoll, J. Ena, J.C. Arévalo-Lorido. Efecto de semaglutida sobre los biomarcadores de la enfermedad del hígado graso en pacientes con diabetes y obesidad. Revista Clínica Española 2023; 223(3) doi: 10.1016/j.rce.2022.11.007
88
Mohammad Habibullah, Khaleed Jemmieh, Amr Ouda, Mohammad Zulqurnain Haider, Mohammed Imad Malki, Abdel-Naser Elzouki. Metabolic-associated fatty liver disease: a selective review of pathogenesis, diagnostic approaches, and therapeutic strategies. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1291501
89
Aurelio Seidita, Alessandra Cusimano, Alessandra Giuliano, Maria Meli, Antonio Carroccio, Maurizio Soresi, Lydia Giannitrapani. Oxidative Stress as a Target for Non-Pharmacological Intervention in MAFLD: Could There Be a Role for EVOO?. Antioxidants 2024; 13(6) doi: 10.3390/antiox13060731
90
M. Gaschinard, C. Tetard, D. Lamireau, J.-F. Chateil, B. Le Bail, H. Thibault, D. Guimber, T. Lamireau, R. Enaud. Découverte d’une stéatose hépatique chez l’enfant. Perfectionnement en Pédiatrie 2021; 4(1) doi: 10.1016/j.perped.2021.01.004
91
Zhi-Sen Pan, Yan-Ling Chen, Kai-Jia Tang, Zhang-Zhou Liu, Jia-Li Liang, Yan-Hao Guan, Xiao-Yi Xin, Chang-Hui Liu, Chuang-Peng Shen. Pachymic acid modulates sirtuin 6 activity to alleviate lipid metabolism disorders. Experimental and Therapeutic Medicine 2023; 26(1) doi: 10.3892/etm.2023.12019
92
Giovanni Catalano, Odysseas P. Chatzipanagiotou, Jun Kawashima, Timothy M. Pawlik. Metabolic-associated steatotic liver disease and hepatocellular carcinoma. Expert Opinion on Pharmacotherapy 2024; 25(17) doi: 10.1080/14656566.2024.2426680
93
Xing Yan, Linnan Li, Pei Liu, Jie Xu, Zhengtao Wang, Lili Ding, Li Yang. Targeted metabolomics profiles serum fatty acids by HFD induced non-alcoholic fatty liver in mice based on GC-MS. Journal of Pharmaceutical and Biomedical Analysis 2022; 211 doi: 10.1016/j.jpba.2022.114620
94
Shujun Wang, Haichao Wang, Guoliang Yin, Xuehuan Liu, Na Xie, Xin Zhang, Wenfei Yu, Haiyi Zhang, Yuqing Sun, Hongshuai Liu, Linya Wang, Muxi Qi, Huagui Feng, Fengxia Zhang. Polydatin improves mitochondrial dynamics dysrhythmia by regulating BMAL1 to prevent and treat metabolic dysfunction-associated fatty liver disease. Journal of Ethnopharmacology 2027; 372 doi: 10.1016/j.jep.2026.122195
95
Oana Timofte, Alexandru Sidencu, Lilia Lica, Elena Gologan. Steatosis - Causes and Treatment. 2025;  doi: 10.5772/intechopen.1012216
96
Karthik Shree Harini, Devaraj Ezhilarasan. Wnt/beta‐catenin signaling and its modulators in nonalcoholic fatty liver diseases. Hepatobiliary & Pancreatic Diseases International 2023; 22(4) doi: 10.1016/j.hbpd.2022.10.003
97
Md. Arifur Rahman Chowdhury, Jungeun An, Sangyun Jeong. The Pleiotropic Face of CREB Family Transcription Factors. Molecules and Cells 2023; 46(7) doi: 10.14348/molcells.2023.2193
98
Xiaowei Gong, Siyu Bai, Enze Lei, Tao Lu, Yao Chen, Jianxin Cai, Jianzhong Liu. A bibliometric analysis of metabolic dysfunction-associated steatotic liver disease in children from 2004 to 2024. Frontiers in Pediatrics 2025; 13 doi: 10.3389/fped.2025.1468788
99
Qin Guo, Yun Li, Xin Dai, Bangmao Wang, Jie Zhang, Hailong Cao. Polysaccharides: The Potential Prebiotics for Metabolic Associated Fatty Liver Disease (MAFLD). Nutrients 2023; 15(17) doi: 10.3390/nu15173722
100
Ebe D'Adamo, Valeria Castorani, Valerio Nobili. The Liver in Children With Metabolic Syndrome. Frontiers in Endocrinology 2019; 10 doi: 10.3389/fendo.2019.00514
101
Joon Beom Park, Kangeun Ko, Yang Hyun Baek, Woo Young Kwon, Sunghwan Suh, Song-Hee Han, Yun Hak Kim, Hye Young Kim, Young Hyun Yoo. Pharmacological Prevention of Ectopic Erythrophagocytosis by Cilostazol Mitigates Ferroptosis in NASH. International Journal of Molecular Sciences 2023; 24(16) doi: 10.3390/ijms241612862
102
Rahiya Rehman. Role of glucagon-like peptide-1 receptor agonists in pediatric obesity and metabolic dysfunction associated steatotic liver disease. World Journal of Clinical Pediatrics 2025; 14(3): 105731 doi: 10.5409/wjcp.v14.i3.105731
103
Yishui Cai, Tianqi Nie, Xi Luo, Yiqun Wu, Jun Wu. Nanotechnology-driven biomaterials for chronic liver diseases: Stage-specific strategies for advanced theranostics. Acta Biomaterialia 2026; 212 doi: 10.1016/j.actbio.2026.01.043
104
Ming-Lu Wang, Gao-Qiang Luo, Xin-Ran Guo, Yu-Qiang Liu. Comparative efficacy of drugs with different mechanistic pathways/targets in the treatment of pediatric NAFLD: evidence from a Bayesian network meta-analysis. Frontiers in Pharmacology 2026; 17 doi: 10.3389/fphar.2026.1777515
105
Jie‐Lei Zhang, Bin‐Bin Du, Dian‐Hong Zhang, Huan Li, Ling‐Yao Kong, Guang‐Jian Fan, Ya‐Peng Li, Peng‐Cheng Li, Cui Liang, Zheng Wang, Lu‐Lu Yang, Zheng‐Yang Hao, Lei‐Ming Wu, Zhen Huang, Jian‐Zeng Dong, Jin‐Ying Zhang, Rui Yao, Shou‐Jun Wang, Yan‐Zhou Zhang. OTUB1 alleviates NASH through inhibition of the TRAF6‐ASK1 signaling pathways. Hepatology 2022; 75(5) doi: 10.1002/hep.32179
106
Resthie R. Putri, Thomas Casswall, Emilia Hagman. Risk and protective factors of non‐alcoholic fatty liver disease in paediatric obesity: A nationwide nested case–control study. Clinical Obesity 2022; 12(2) doi: 10.1111/cob.12502
107
Weisong Cai, Sa Wu, Xiaoping Ming, Zhen Li, Dingyu Pan, Xiuping Yang, Minlan Yang, Yufeng Yuan, Xiong Chen. IL6 Derived from Macrophages under Intermittent Hypoxia Exacerbates NAFLD by Promoting Ferroptosis via MARCH3‐Led Ubiquitylation of GPX4. Advanced Science 2024; 11(41) doi: 10.1002/advs.202402241
108
Yingyi Huang, Xiang Liu, Hong-Yan Wang, Jian-Yang Chen, Xianghui Zhang, Yubang Li, Yifang Lu, Zhongdian Dong, Kaiqiang Liu, Zhongduo Wang, Qian Wang, Guangyi Fan, Jun Zou, Shanshan Liu, Changwei Shao. Single-cell transcriptome landscape of zebrafish liver reveals hepatocytes and immune cell interactions in understanding nonalcoholic fatty liver disease. Fish & Shellfish Immunology 2024; 146 doi: 10.1016/j.fsi.2024.109428
109
Moumita Saha, Krishnendu Manna, Krishna Das Saha. Melatonin Suppresses NLRP3 Inflammasome Activation via TLR4/NF-κB and P2X7R Signaling in High-Fat Diet-Induced Murine NASH Model. Journal of Inflammation Research 2022;  doi: 10.2147/JIR.S343236
110
ChenLu Zhao, JunHao Shi, DongFang Shang, Min Guo, Cheng Zhou, WenXia Zhao. Protective effect of phytoestrogens on nonalcoholic fatty liver disease in postmenopausal women. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1237845
111
Li-ping Zhang, Hua-xing Wei, Shi-hui Lin, Bin-wei Qiu, Jin-liang Lin. Cotinine exposure enhances the association of blood manganese and non-alcoholic fatty liver disease in American children: a cross-sectional study. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-75298-0
112
Arnab Banerjee, Debasmita Das, Rajarshi Paul, Sandipan Roy, Ujjal Das, Samrat Saha, Sanjit Dey, Arghya Adhikary, Sandip Mukherjee, Bithin Kumar Maji. Mechanistic study of attenuation of monosodium glutamate mixed high lipid diet induced systemic damage in rats by Coccinia grandis. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-72076-6
113
Zoran Gluvic, Ratko Tomasevic, Ksenija Bojovic, Milan Obradovic, Esma R. Isenovic. Non-alcoholic fatty liver disease: a multidisciplinary clinical practice approach—the institutional adaptation to existing Clinical Practice Guidelines. Emergency and Critical Care Medicine 2022; 2(1) doi: 10.1097/EC9.0000000000000016
114
Xiaomin Luo, Boyu Zhang, Yehua Pan, Jian Gu, Rui Tan, Puyang Gong. Phyllanthus emblica aqueous extract retards hepatic steatosis and fibrosis in NAFLD mice in association with the reshaping of intestinal microecology. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.893561
115
. 2021;  doi: 10.70675/84e2e5fdze227z4f31zb2dez9d36beb885a4
116
Reham Mohammed Dawood, Ghada Maher Salum, Mai Abd El-Meguid, Basma EL-sayed Fotouh. Molecular Insights of Nonalcoholic Fatty Liver Disease Pathogenesis. Journal of Interferon & Cytokine Research 2024; 44(3) doi: 10.1089/jir.2023.0162
117
Carolina Gabriela Plazas Guerrero, Selene De Jesús Acosta Cota, Francisco Humberto Castro Sánchez, Marcela De Jesús Vergara Jiménez, Efrén Rafael Ríos Burgueño, Juan Ignacio Sarmiento Sánchez, Lorenzo Antonio Picos Corrales, Ulises Osuna Martínez. Evaluation of sucrose-enriched diet consumption in the development of risk factors associated to type 2 diabetes, atherosclerosis and non-alcoholic fatty liver disease in a murine model. International Journal of Environmental Health Research 2021; 31(6) doi: 10.1080/09603123.2019.1680817
118
Amirhossein Tamimi, Mona Javid, Nasrin Sedighi-Pirsaraei, Arian Mirdamadi. Exosome prospects in the diagnosis and treatment of non-alcoholic fatty liver disease. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1420281
119
Amr Ali Mohamed Abdelgawwad El-Sehrawy, Abdulsalam Najm Mohammed, Jitendra Gupta, Jaafaru Sani Mohammed, R. Roopashree, Aditya Kashyap, Bethanney Janney J, Samir Sahoo, Shaker Al-Hasnaawei, Yassir Mohammed Nasr. Combating oxidative stress in non-alcoholic fatty liver disease: From mechanisms to therapeutic strategies. Pathology - Research and Practice 2025; 272 doi: 10.1016/j.prp.2025.156053
120
Evelyn Nunes Goulart da Silva Pereira, Daniela Polessa Paula, Beatriz Peres de Araujo, Maria de Jesus Mendes da Fonseca, Maria de Fátima Haueisen Sander Diniz, Anissa Daliry, Rosane Harter Griep. Advanced glycation end product: A potential biomarker for risk stratification of non-alcoholic fatty liver disease in ELSA-Brasil study. World Journal of Gastroenterology 2021; 27(29): 4913-4928 doi: 10.3748/wjg.v27.i29.4913
121
Priyankar Dey, Richard S. Bruno. Dietary Supplements with Antioxidant Activity. 2023;  doi: 10.1039/BK9781839166112-00080
122
Sina Kalantari Soltanieh, Sahar Khastar, Irwanjot Kaur, Abhishek Kumar, Jaya Bansal, Ata Fateh, Deepak Nathiya, Beneen Husseen, Mansour Rajabivahid, Mahmoud Dehghani-Ghorbi, Reza Akhavan-Sigari. Long Non-Coding RNAs in Non-Alcoholic Fatty Liver Disease; Friends or Foes?. Cell Biochemistry and Biophysics 2024; 83(1) doi: 10.1007/s12013-024-01555-8
123
Athanasios N. Tsartsalis, Anna Tagka, Athanasios Kotoulas, Daphne Mirkopoulou, Styliani A. Geronikolou, Lambrou G. GeNeDis 2020. Advances in Experimental Medicine and Biology 2021; 1338 doi: 10.1007/978-3-030-78775-2_14
124
S. Shamsher S Kalra, Balakrishnan Sadasivam, Ahmad Najmi, Jai K Chaurasia. Comparative Evaluation of the Effects of Oral Anti-hyperglycemic Agents and an Ayurvedic Hepatoprotective Agent in a Rat Model of Non-alcoholic Fatty Liver Disease (NAFLD). Cureus 2025;  doi: 10.7759/cureus.99891
125
Songsong Wang, Feiya Sheng, Liang Zou, Jianbo Xiao, Peng Li. Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism. Journal of Advanced Research 2021; 34 doi: 10.1016/j.jare.2021.06.001
126
J.B. Armengaud, C. Yzydorczyk, B. Siddeek, A.C. Peyter, U. Simeoni. Intrauterine growth restriction: Clinical consequences on health and disease at adulthood. Reproductive Toxicology 2021; 99 doi: 10.1016/j.reprotox.2020.10.005
127
Abdul Moeed, Muhammad Omar Larik, Muhammad Ahmed Ali Fahim, Hafsah Alim Ur Rahman, Lubna Najmi, Mah I Kan Changez, Muhammad Moiz Javed, Md Al Hasibuzzaman. Impact of non-alcoholic fatty liver disease on coronavirus disease 2019: A systematic review. World Journal of Hepatology 2024; 16(8): 1185-1198 doi: 10.4254/wjh.v16.i8.1185
128
Katarzyna Marcinkiewicz, Anita Horodnicka-Józwa, Tomasz Jackowski, Kamila Strączek, Agnieszka Biczysko-Mokosa, Mieczysław Walczak, Elżbieta Petriczko. Nonalcoholic fatty liver disease in children with obesity– observations from one clinical centre in the Western Pomerania region. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.992264
129
Pin-Nan Cheng, Wen-Jone Chen, Charles Jia-Yin Hou, Chih-Lin Lin, Ming-Ling Chang, Chia-Chi Wang, Wei-Ting Chang, Chao-Yung Wang, Chun-Yen Lin, Chung-Lieh Hung, Cheng-Yuan Peng, Ming-Lung Yu, Ting-Hsing Chao, Jee-Fu Huang, Yi-Hsiang Huang, Chi-Yi Chen, Chern-En Chiang, Han-Chieh Lin, Yi-Heng Li, Tsung-Hsien Lin, Jia-Horng Kao, Tzung-Dau Wang, Ping-Yen Liu, Yen-Wen Wu, Chun-Jen Liu. Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction- associated fatty liver disease and cardiovascular diseases. Clinical and Molecular Hepatology 2023; 30(1) doi: 10.3350/cmh.2023.0315
130
A comparative study on the effect of melatonin and orlistat combination versus orlistat alone on high fat diet-induced hepatic changes in the adult male albino rats (a histological and morphometric study). Ultrastructural Pathology 2025; 49(1) doi: 10.1080/01913123.2024.2438380
131
Wenji Zhang, Hui Lin, Wenli Cheng, Zhenrui Huang, Wenjuan Zhang. Protective Effect and Mechanism of Plant-Based Monoterpenoids in Non-alcoholic Fatty Liver Diseases. Journal of Agricultural and Food Chemistry 2022; 70(16) doi: 10.1021/acs.jafc.2c00744
132
Ludovico Abenavoli, Anna Caterina Procopio, Maria Rosaria Paravati, Giosuè Costa, Nataša Milić, Stefano Alcaro, Francesco Luzza. Mediterranean Diet: The Beneficial Effects of Lycopene in Non-Alcoholic Fatty Liver Disease. Journal of Clinical Medicine 2022; 11(12) doi: 10.3390/jcm11123477
133
Farah D.R. Al-Baiaty, Aziana Ismail, Zarina Abdul Latiff, Khairul Najmi Muhammad Nawawi, Raja Affendi Raja Ali, Norfilza Mohd Mokhtar. Possible Hepatoprotective Effect of Tocotrienol-Rich Fraction Vitamin E in Non-alcoholic Fatty Liver Disease in Obese Children and Adolescents. Frontiers in Pediatrics 2021; 9 doi: 10.3389/fped.2021.667247
134
Kexin Tao, Han Peng, Xin Bi, Xiaoya Wang, Yue Tian, Hua Zhang, Yong Sun. Effect of Tetrastigma hemsleyanum leaves and Extract supplementation on liver metabolomics and the gut microbiota in alcohol-induced liver injury. Food Bioscience 2024; 58 doi: 10.1016/j.fbio.2024.103617
135
Subramaniyam Nithyananthan, Dangudubiyyam Sushmaa, Ibansiewdor Myrthong, Lokanatha Valluru, Shreyoshi Guha, Ishfaq Hassan Mir, Jajnasenee Behera, Chinnasamy Thirunavukkarasu. Curcuma longaandTrigonella foenum graecum‐enriched nutrient mixture from germinatedMacrotyloma uniflorumandVigna radiateameliorate nonalcoholic fatty liver diseases in rats. Journal of Food Biochemistry 2020; 44(4) doi: 10.1111/jfbc.13159
136
P. Ye, L. Gao, Z. Xia, L. Peng, X. Shi, J. Ma, Y. Dong, D. Dai, Q. Yang, X. Chen, X. Fan, N. Wan, J. Zhang, B. Li, L. Zhou, G. Wu, L. Yang, X. Li, Y. Yan, Y. He. Association between non-alcoholic fatty liver disease and metabolic abnormalities in children with different weight statuses. Public Health 2024; 235 doi: 10.1016/j.puhe.2024.06.004
137
Madalina Andreea Robea, Ioana-Miruna Balmus, Irina Girleanu, Laura Huiban, Cristina Muzica, Alin Ciobica, Carol Stanciu, Carmen Diana Cimpoesu, Anca Trifan. Coagulation Dysfunctions in Non-Alcoholic Fatty Liver Disease—Oxidative Stress and Inflammation Relevance. Medicina 2023; 59(9) doi: 10.3390/medicina59091614
138
Arash Karimi, Mahdi Vajdi, Sarvin Sanaie, Shiva Akhlaghi, Aida Negari, Farzaneh Dashti, Pouria Sefidmooye Azar, Rafik Balti. A Comprehensive Insight into the Effect of Berberine on Nonalcoholic Fatty Liver Disease (NAFLD): A Systematic Review. Journal of Food Biochemistry 2023; 2023 doi: 10.1155/2023/7277060
139
Yigui Zou, Yu Dai, Ziyuan Li, Baixian Lin, Hu Chen, Zeling Zhuang, Wenwen Li, Qinghua Yang, Dongling Dai. Modified triglyceride-glucose indices as novel predictors of metabolic dysfunction-associated fatty liver disease in US adolescents: a nationally representative study from NHANES 2017–2020. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-03915-x
140
Raquel Cano, José Pérez, Lissé Dávila, Ángel Ortega, Yosselin Gómez, Nereida Valero-Cedeño, Heliana Parra, Alexander Manzano, Teresa Véliz Castro, María Albornoz, Gabriel Cano, Joselyn Rojas-Quintero, Maricarmen Chacín, Valmore Bermúdez. Role of Endocrine-Disrupting Chemicals in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: A Comprehensive Review. International Journal of Molecular Sciences 2021; 22(9) doi: 10.3390/ijms22094807
141
Zeyu Li, Hong Wang, Kanglin Wu, Lianfeng Zhang. Omarigliptin protects against nonalcoholic fatty liver disease by ameliorating oxidative stress and inflammation. Journal of Biochemical and Molecular Toxicology 2021; 35(12) doi: 10.1002/jbt.22914
142
Jernej Brecelj, Rok Orel. Non-Alcoholic Fatty Liver Disease in Children. Medicina 2021; 57(7) doi: 10.3390/medicina57070719
143
I-Chuan Yen, Jung-Chun Lin, Yu Chen, Qian-Wen Tu, Shih-Yu Lee. Antrodia Cinnamomea Attenuates Non-Alcoholic Steatohepatitis by Suppressing NLRP3 Inflammasome Activation In Vitro and In Vivo. The American Journal of Chinese Medicine 2020; 48(08) doi: 10.1142/S0192415X20500937
144
Attia Mustafa, Chris Kite, Lukasz Lagojda, Alexander Dallaway, Kamaljit Kaur Chatha, Nwe Ni Than, Eva Kassi, Ioannis Kyrou, Harpal S. Randeva. Cardiovascular Disease in the Context of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Comprehensive Narrative Review. International Journal of Molecular Sciences 2025; 26(23) doi: 10.3390/ijms262311275
145
Otilia Frasinariu, Roxana Serban, Laura Mihaela Trandafir, Ingrith Miron, Magdalena Starcea, Ioana Vasiliu, Anna Alisi, Oana Raluca Temneanu. The Role of Phytosterols in Nonalcoholic Fatty Liver Disease. Nutrients 2022; 14(11) doi: 10.3390/nu14112187
146
Ying-Le Tang, Lin Zhu, Yan Tao, Wen Lu, Hong Cheng. Role of targeting TLR4 signaling axis in liver-related diseases. Pathology - Research and Practice 2023; 244 doi: 10.1016/j.prp.2023.154410
147
Irina A. Komissarenko, Svetlana V. Levchenko. The use of pleiotropic effects of some gastroenterological drugs in the treatment of patients with non-alcoholic fatty liver disease and cardiovascular diseases: A review. Consilium Medicum 2024; 26(12) doi: 10.26442/20751753.2024.12.203090
148
Rong Xie, Shaodong Chen, Fang Li, Liu Yang, Bangliang Yu. Pirfenidone attenuates nonalcoholic fatty liver disease through activation of the nuclear factor erythroid 2‐related factor 2 (Nrf2) signaling pathway. Journal of Biochemical and Molecular Toxicology 2023; 37(2) doi: 10.1002/jbt.23251
149
Lyuzhen Chen, Xuemei Pu, Li Li, Mei Zhang, Yan Liu, Kaisong Hu, Juan Wang, Fan Zhang, Jie Yu. Shenling Jianpiwei formula ameliorates metabolic associated fatty liver disease through modulation of the gut microbiota and attenuation of LPS-mediated inflammation. Fitoterapia 2025; 186 doi: 10.1016/j.fitote.2025.106862
150
Hao Wang, Chunlan Shan, Gangjun Guo, Delu Ning, Fujun Miao. Therapeutic potential of palmitoleic acid in non-alcoholic fatty liver disease: Targeting ferroptosis and lipid metabolism disorders. International Immunopharmacology 2024; 142 doi: 10.1016/j.intimp.2024.113025
151
Wenliang He, Erin A Posey, Chandler C Steele, Jeffrey W Savell, Fuller W Bazer, Guoyao Wu. Dietary glycine supplementation enhances glutathione availability in tissues of pigs with intrauterine growth restriction. Journal of Animal Science 2024; 102 doi: 10.1093/jas/skae025
152
Yu-Qi Li, Lei Xin, Yu-Chi Zhao, Shang-Qi Li, Ya-Nuo Li. Role of vascular endothelial growth factor B in nonalcoholic fatty liver disease and its potential value. World Journal of Hepatology 2023; 15(6): 786-796 doi: 10.4254/wjh.v15.i6.786
153
Yan Yang, Wenting Zhang, Xiaohui Wu, Jing Wu, Chengjun Sun, Feihong Luo, Zhou Pei, Fernand Pierre Gendron. Systemic Overexpression of GDF5 in Adipocytes but Not Hepatocytes Alleviates High‐Fat Diet‐Induced Nonalcoholic Fatty Liver in Mice. Canadian Journal of Gastroenterology and Hepatology 2021; 2021(1) doi: 10.1155/2021/8894685
154
Hunter W. Korsmo, Hrutvik Bhavsar, Steven Trasino, Jorge Matias Caviglia, Xinyin Jiang. Prenatal and postnatal choline supplementation alters metabolic dysfunction-associated steatohepatitis (MASH) phenotypes in offspring exposed to maternal obesity and following a western diet into adulthood: A preliminary study. The Journal of Nutritional Biochemistry 2026; 154 doi: 10.1016/j.jnutbio.2026.110354
155
Amira M. Badr, Iman O. Sherif, Yasmen F. Mahran, Hala A. Attia. The Renin Angiotensin System in Cancer, Lung, Liver and Infectious Diseases. Advances in Biochemistry in Health and Disease 2023; 25 doi: 10.1007/978-3-031-23621-1_10
156
Rachmad Anres Dongoran, Fang-Cen Tu, Chin-Hung Liu. Current insights into the interplay between gut microbiota-derived metabolites and metabolic-associated fatty liver disease. Tzu Chi Medical Journal 2023; 35(4) doi: 10.4103/tcmj.tcmj_122_23
157
Weiju Xue, Jiarong Wang, Wei Jiang, Congjian Shi, Xiaohong Wang, Yan Huang, Chengmu Hu. Caveolin-1 alleviates lipid accumulation in NAFLD associated with promoting autophagy by inhibiting the Akt/mTOR pathway. European Journal of Pharmacology 2020; 871 doi: 10.1016/j.ejphar.2020.172910
158
Pentraxin 3 and the TyG Index as Two Novel Markers to Diagnose NAFLD in Children. Disease Markers 2021; 2021 doi: 10.1155/2021/8833287
159
Danting Mao, Jianwei Guo, Kunli Yang, Fan Yang, Jiaojiao Peng, Xu Jia, Ziren Luo, Lu Liu, Enjie Yang, Rui Tang, Haitao Lan, Qian Zheng. Mechanism of epigallocatechin gallate in treating non-alcoholic fatty liver disease: Insights from network pharmacology and experimental validation. Biochemical and Biophysical Research Communications 2024; 734 doi: 10.1016/j.bbrc.2024.150424
160
. 2023;  doi: 10.70675/73015fe4z4df2z44bdza09cz0f9fc70e9953
161
Cristiane Cosmo Silva-Luis, Mariana Souza Lopes, Sávio Marcelino Gomes, Palloma Karlla Cantalice Matias, Fernando Paiva Brandini, Paulo César Trindade Costa, Rúbia Cartaxo Squizato de Moraes, Vinícius José Baccin Martins, José Luiz de Brito Alves. Ultra-Processed Food Consumption and Cardiometabolic Risk Factors in Children Living in Northeastern Brazil. Nutrients 2024; 16(22) doi: 10.3390/nu16223944
162
Haoran Chen, Xiaofen Qi, Kaifang Guan, Yuxiang Gu, Rongchun Wang, Qiming Li, Ying Ma. Peptides released from bovine α-lactalbumin by simulated digestion alleviated free fatty acids-induced lipid accumulation in HepG2 cells. Journal of Functional Foods 2021; 85 doi: 10.1016/j.jff.2021.104618
163
V V Sathibabu Uddandrao, Deepthi Krishna, Mallenahalli Neelakantappa Vasantha, G. Jayashree, Anitha Roy, V.R. Ravikkumar, S. Sengottuvelu, P. Chandrasekaran, C. Kathirvelan, Brahma Naidu Parim, Kaushik Das, Umesh Kumar. Combination of hydroxycitric acid and capsaicin regulates IRS-1/AMPK-mTOR-SREBP-1c Axis/NLRP3-NF-κB/Nrf-2-ARE signaling pathways to ameliorate the two-hit process in high-fat diet-induced hepatic steatosis. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2025; 1870(8) doi: 10.1016/j.bbalip.2025.159682
164
Lin Ji, Huan Deng, Huimin Xue, Jiting Wang, Kexin Hong, Yunxiao Gao, Xiping Kang, Guanghe Fan, Weidong Huang, Jicheng Zhan, Yilin You. Research progress regarding the effect and mechanism of dietary phenolic acids for improving nonalcoholic fatty liver disease via gut microbiota. Comprehensive Reviews in Food Science and Food Safety 2023; 22(2) doi: 10.1111/1541-4337.13106
165
Yunfei Xing, Jiangao Fan, Hai-Jun Wang, Hui Wang. Comparison of MAFLD and NAFLD Characteristics in Children. Children 2023; 10(3) doi: 10.3390/children10030560
166
Kai Ushio, Yukio Mikami, Hiromune Obayashi, Hironori Fujishita, Kouki Fukuhara, Tetsuhiko Sakamitsu, Kazuhiko Hirata, Yasunari Ikuta, Hiroaki Kimura, Nobuo Adachi. Decreased Muscle-to-Fat Mass Ratio Is Associated with Low Muscular Fitness and High Alanine Aminotransferase in Children and Adolescent Boys in Organized Sports Clubs. Journal of Clinical Medicine 2021; 10(11) doi: 10.3390/jcm10112272
167
Gulsah Kaya Aksoy, Reha Artan, Cihat Aksoy, Sebahat Özdem, Atike Atalay, Aygen Yılmaz. Role of Soluble Adiponectin Receptor 2 in Non-Alcoholic Fatty Liver Disease in Children. Pediatric Gastroenterology, Hepatology & Nutrition 2019; 22(5) doi: 10.5223/pghn.2019.22.5.470
168
Eric Kalo, Scott Read, Golo Ahlenstiel. Targeting Gut–Liver Axis for Treatment of Liver Fibrosis and Portal Hypertension. Livers 2021; 1(3) doi: 10.3390/livers1030014
169
Bohyun Park, Byungmi Kim, Chung Ho Kim, Hyun Jin Oh, Bomi Park. Association between endocrine-disrupting chemical mixtures and non-alcoholic fatty liver disease with metabolic syndrome as a mediator among adults: A population-based study in Korea. Ecotoxicology and Environmental Safety 2024; 276 doi: 10.1016/j.ecoenv.2024.116310
170
Ryutaro Kuraji, Satoshi Sekino, Yvonne Kapila, Yukihiro Numabe. Periodontal disease–related nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: An emerging concept of oral‐liver axis. Periodontology 2000 2021; 87(1) doi: 10.1111/prd.12387
171
Ningning Chen, Qiuli Shan, Yu Qi, Wei Liu, Xiaojun Tan, Jinsong Gu. Transcriptome analysis in normal human liver cells exposed to 2, 3, 3′, 4, 4′, 5 - Hexachlorobiphenyl (PCB 156). Chemosphere 2020; 239 doi: 10.1016/j.chemosphere.2019.124747
172
Yi Chen, Xueyang Chen, Qiang Chen, Chaohui Yu. Non-Alcoholic Fatty Liver Disease and Hypokalemia in Primary Aldosteronism Among Chinese Population. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.565714
173
Alby Tom, Arunaksharan Narayanankutty. Coconut Haustorium Alleviates Fructose-Induced Redox Imbalance, Lipotoxicity and Metabolic Stress in Cultured Hepatocytes. Journal of the American Nutrition Association 2026;  doi: 10.1080/27697061.2026.2719461
174
Siti Aishah Sulaiman, Vicneswarry Dorairaj, Muhammad Nafiz Haidi Adrus. Genetic Polymorphisms and Diversity in Nonalcoholic Fatty Liver Disease (NAFLD): A Mini Review. Biomedicines 2022; 11(1) doi: 10.3390/biomedicines11010106
175
Doaa El Amrousy, Dalia El-Afify, Esraa Abd Al-Fattah Sorour, Shymaa Elrifaey. Effect of Lactoferrin in Obese Children and Adolescents with Metabolic Dysfunction-Associated Steatotic Disease: A Randomized Controlled Study. Pediatric Drugs 2026; 28(3) doi: 10.1007/s40272-026-00742-9
176
Tianyu Jiang, Yao Xiao, Jinfeng Zhou, Zupeng Luo, Lin Yu, Qichao Liao, Siqi Liu, Xinyi Qi, Hao Zhang, Menglong Hou, WeiWei Miao, Batbold Batsaikhan, Turtushikh Damba, Yunxiao Liang, Yixing Li, Lei Zhou. Arbutin alleviates fatty liver by inhibiting ferroptosis via FTO/SLC7A11 pathway. Redox Biology 2023; 68 doi: 10.1016/j.redox.2023.102963
177
Fan Yang, Xiaoping Tan. Progress in the Study of the Hepatoprotective Effect of SGLT2i on NAFLD Patients with T2DM. Journal of Biosciences and Medicines 2024; 12(01) doi: 10.4236/jbm.2024.121011
178
Ebrahim Abbasi Oshaghi. Role of Toll-like Receptor 4 in the Development of Non-alcoholic Fatty Liver Disease. Avicenna Journal of Medical Biochemistry 2018; 6(2) doi: 10.15171/ajmb.2018.06
179
Costanza Renata Neri, Serena Scapaticci, Francesco Chiarelli, Cosimo Giannini. Liver Steatosis: A Marker of Metabolic Risk in Children. International Journal of Molecular Sciences 2022; 23(9) doi: 10.3390/ijms23094822
180
Haiyan Liu, Jie Xu, Hui Li, Lina Zhang, Pingzhen Xu. Network pharmacology‐based investigation to explore the effect and mechanism of Erchen decoction against the nonalcoholic fatty liver disease. The Anatomical Record 2021; 304(11) doi: 10.1002/ar.24770
181
Shuai Wu, Ning Guo, Hanlin Xu, Yu Li, Tianyin Sun, Xiangfu Jiang, Dongdong Fu, Tingyu You, Shaoxi Diao, Yan Huang, Chengmu Hu. Caveolin-1 ameliorates hepatic injury in non-alcoholic fatty liver disease by inhibiting ferroptosis via the NOX4/ROS/GPX4 pathway. Biochemical Pharmacology 2024; 230 doi: 10.1016/j.bcp.2024.116594
182
Yuanshe Huang, Xiaodong Wang, Lai Zhang, Ke Zheng, Jie Xiong, Jing Li, Chunlei Cong, Zhaomiao Gong, Jingxin Mao, Lei Chen. Effect of Probiotics Therapy on Nonalcoholic Fatty Liver Disease. Computational and Mathematical Methods in Medicine 2022; 2022 doi: 10.1155/2022/7888076
183
S. V. Orlova, A. N. Vodolazkaya, O. I. Tarasova, E. A. Nikitina, E. V. Prokopenko, N. V. Balashova, I. S. Minosyan, V. V. Urazov. Phytonutrients in complex diet therapy for alcoholic liver disease and non-alcoholic fatty liver disease. Medical alphabet 2024; (16) doi: 10.33667/2078-5631-2024-16-13-18
184
Syeda Farha S, Sheetal R. Diet and Non-Alcoholic Fatty Liver Disease (NAFLD): Advances and Management Strtegies : A Comprehensive Review. Journal of Community Medicine and Public Health Research 2025; 6(1) doi: 10.20473/jcmphr.v6i1.60756
185
Priyanka Budhwani, Bikas Goswani, Somiddho Debnath, Aparna Shukla. Prevalence of Metabolic Dysfunction-Associated Steatotic Liver Disease Among Overweight and Obese Patients With Type 2 Diabetes Mellitus. Cureus 2025;  doi: 10.7759/cureus.99670
186
Ying-Xin Xian, Jian-Ping Weng, Fen Xu. MAFLD vs. NAFLD: shared features and potential changes in epidemiology, pathophysiology, diagnosis, and pharmacotherapy. Chinese Medical Journal 2021; 134(1) doi: 10.1097/CM9.0000000000001263
187
Margherita Finazzi, Federica Bovio, Matilde Forcella, Marina Lasagni, Paola Fusi, Jessica Zampolli, Patrizia Di Gennaro. Fructooligosaccharides-driven metabolism of a defined Lactobacillus probiotic consortium modulates hepatic lipid accumulation in a reductionist in vitro gut microbiota–liver interaction model. Frontiers in Microbiology 2026; 17 doi: 10.3389/fmicb.2026.1866842
188
Linyin Huang, Shifang Qu, Xinyu Cui, Yujin Jin, Yan Yao. Association between oxidative stress and metabolic-associated fatty liver disease in the US population. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-05044-7
189
Di Xiao, Xingxing Cui, Sajad Ali, Changfei Li, Bin Wang. Targeting Mitochondria in MASLD: Comparative Evaluation of MitoQ and SS-31 (Elamipretide) in Aged Female Mice under Nutritional Stress. Physiological Research 2026; 75(4) doi: 10.33549/physiolres.935810
190
Ziming Mao, Xiaowen Ma, Yu Jing, Minyan Shen, Xirui Ma, Jing Zhu, Huifang Liu, Guangya Zhang, Fengling Chen. Ufmylation on UFBP1 alleviates non-alcoholic fatty liver disease by modulating hepatic endoplasmic reticulum stress. Cell Death & Disease 2023; 14(9) doi: 10.1038/s41419-023-06095-2
191
Meiqi Fan, Young-Jin Choi, Yujiao Tang, Sung Mun Bae, Hyun Pil Yang, Eun-Kyung Kim. Efficacy and Mechanism of Polymerized Anthocyanin from Grape-Skin Extract on High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease. Nutrients 2019; 11(11) doi: 10.3390/nu11112586
192
Jiang Du, Yu Ji, Liang Qiao, Yanli Liu, Juntang Lin. Cellular endo‐lysosomal dysfunction in the pathogenesis of non‐alcoholic fatty liver disease. Liver International 2020; 40(2) doi: 10.1111/liv.14311
193
Ludovico Abenavoli, Maria Luisa Gambardella, Giuseppe Guido Maria Scarlata, Ilaria Lenci, Leonardo Baiocchi, Francesco Luzza. The Many Faces of Metabolic Dysfunction-Associated Fatty Liver Disease Treatment: From the Mediterranean Diet to Fecal Microbiota Transplantation. Medicina 2024; 60(4) doi: 10.3390/medicina60040563
194
Valeria Calcaterra, Vittoria Magenes, Matteo Vandoni, Clarissa Berardo, Luca Marin, Alice Bianchi, Erika Cordaro, Giustino Silvestro, Dario Silvestri, Vittoria Carnevale Pellino, Cristina Cereda, Gianvincenzo Zuccotti. Benefits of Physical Exercise as Approach to Prevention and Reversion of Non-Alcoholic Fatty Liver Disease in Children and Adolescents with Obesity. Children 2022; 9(8) doi: 10.3390/children9081174
195
Wei Song, Tianyi Wang, Xiaole Cui, Lingling Li, Bing Chen, Yanjie Li, Tianli Yue. Lactobacillus coryniformis subsp. torquensT3 alleviates non‐alcoholic fatty liver disease via reconstruction of the gut microbiota and redox system. Journal of the Science of Food and Agriculture 2023; 103(14) doi: 10.1002/jsfa.12774
196
Nan Zhou, Susu Du, Yanyan Dai, Fan Yang, Xiaonan Li. ω3PUFAs improve hepatic steatosis in postnatal overfed rats and HepG2 cells by inhibiting acetyl‐CoA carboxylase. Food Science & Nutrition 2021; 9(9) doi: 10.1002/fsn3.2482
197
Hwa‐Li Tan, Shamsul Mohd Zain, Hooi‐Sian Eng, Zahurin Mohamed, Sanjiv Mahadeva, Wah‐Kheong Chan, Peng‐Choong Lau, Roma Choudhury Basu, Rosmawati Mohamed. Allele HLA‐DQB1*06 reduces fibrosis score in patients with non‐alcoholic fatty liver disease. Hepatology Research 2020; 50(8) doi: 10.1111/hepr.13525
198
Guillermo Santos-Sánchez, Ivan Cruz-Chamorro, Ana Isabel Álvarez-Ríos, José María Fernández-Santos, María Victoria Vázquez-Román, Beatriz Rodríguez-Ortiz, Nuria Álvarez-Sánchez, Ana Isabel Álvarez-López, María del Carmen Millán-Linares, Francisco Millán, Justo Pedroche, María Soledad Fernández-Pachón, Patricia Judith Lardone, Juan Miguel Guerrero, Ignacio Bejarano, Antonio Carrillo-Vico. Lupinus angustifolius Protein Hydrolysates Reduce Abdominal Adiposity and Ameliorate Metabolic Associated Fatty Liver Disease (MAFLD) in Western Diet Fed-ApoE−/− Mice. Antioxidants 2021; 10(8) doi: 10.3390/antiox10081222
199
Ping Li, Cunxia Fan, Yingying Cai, Shu Fang, Yanmei Zeng, Yudan Zhang, Xiaochun Lin, Hongbin Zhang, Yaoming Xue, Meiping Guan. Transplantation of brown adipose tissue up-regulates miR-99a to ameliorate liver metabolic disorders in diabetic mice by targeting NOX4. Adipocyte 2020; 9(1) doi: 10.1080/21623945.2020.1721970
200
Guan Lin, Zhang Xinhe, Tian Haoyu, Jin Xing, Li Dan, Wang Ningning, Sun Jing, Wang Xue, Zeng Zilu, Li Yiling. Epidemiology and lifestyle survey of non-alcoholic fatty liver disease in school-age children and adolescents in Shenyang, Liaoning. BMC Pediatrics 2022; 22(1) doi: 10.1186/s12887-022-03351-w
201
Liyuan Hao, Shenghao Li, Guo Chen, Xiaoyu Hu. Regulation of UCP2 in nonalcoholic fatty liver disease: From mechanisms to natural product. Chemical Biology & Drug Design 2024; 103(2) doi: 10.1111/cbdd.14461
202
Yuqing Cheng, Shuangzhe Lin, Tianyi Ren, Jianbin Zhang, Yingying Shi, Yingwei Chen, Yuanwen Chen. New murine model of alcoholic hepatitis in obesity-induced metabolic-associated fatty liver disease. Experimental Animals 2023; 72(3) doi: 10.1538/expanim.22-0160
203
Bin Liu, Huan Zheng, Guanghui Liu, Zhiling Li. Adiponectin is Inversely Associated with Insulin Resistance in Adolescents with Nonalcoholic Fatty Liver Disease. Endocrine, Metabolic & Immune Disorders - Drug Targets 2022; 22(6) doi: 10.2174/1871530321666210927153831
204
Lihua Zhao, Qiuyu Jiang, Jiaqi Lei, Jian Cui, Xianjie Pan, Yuan Yue, Bingkun Zhang. Bile acid disorders and intestinal barrier dysfunction are involved in the development of fatty liver in laying hens. Poultry Science 2024; 103(12) doi: 10.1016/j.psj.2024.104422
205
O. A. Morozova, A. V. Morozova. Differential diagnostic value of serum leptin level and polymorphism of the leptin receptor gene Gln223Arg in metabolic fatty and alcoholic liver diseases. Experimental and Clinical Gastroenterology 2024; (10) doi: 10.31146/1682-8658-ecg-230-10-155-161
206
Pejman Rohani, Shima Shojaie, Ali Nikparast, Mohsen Shaygantabar, Fateme Ettehad Marvasti, Golaleh Asghari, Hanieh-Sadat Ejtahed, Mohammad Hassan Sohouli, Shirin Hasani-Ranjbar, Seyed Davar Siadat, Bagher Larijani, Afshin Ostovar. The association between gut microbiota and metabolic dysfunction-associated steatotic liver disease (MASLD): a case-control study. BMC Pediatrics 2025; 25(1) doi: 10.1186/s12887-025-06144-z
207
Ashraf K. Awaad, Maher A. Kamel, Magdy M. Mohamed, Madiha H. Helmy, Magda I. Youssef, Eiman I. Zaki, Marwa M. Essawy, Marwa G. A. Hegazy. The role of hepatic transcription factor cAMP response element-binding protein (CREB) during the development of experimental nonalcoholic fatty liver: a biochemical and histomorphometric study. Egyptian Liver Journal 2020; 10(1) doi: 10.1186/s43066-020-00046-8
208
Grzegorz Boryczka, Ewa Kosiorowska, Jakub Świętek, Kaja Głowacka, Marek Waluga. Gut microbiome in non-alcoholic fatty liver disease. Polish Journal of Public Health 2022; 132(1) doi: 10.2478/pjph-2022-0002
209
Erika Choi, Ana Ramirez Tovar, Zhulin He, Dellys M. Soler Soler Rodriguez, Miriam B. Vos, Shruthi Arora, Doris Fadoju. Glucagon-like Peptide-1 Receptor Agonists—A Potential New Medication for Pediatric Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD). Children 2024; 11(3) doi: 10.3390/children11030275
210
Resthie R. Putri, Thomas Casswall, Emilia Hagman. Prevalence of increased transaminases and its association with sex, age, and metabolic parameters in children and adolescents with obesity – a nationwide cross-sectional cohort study. BMC Pediatrics 2021; 21(1) doi: 10.1186/s12887-021-02747-4
211
Man Wang, Lei Li, Yannan Xu, Juan Du, Changquan Ling. Roles of hepatic stellate cells in NAFLD: From the perspective of inflammation and fibrosis. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.958428
212
Yajie Chen, Yang Wang, Ziqiang Cui, Wenpeng Liu, Baowang Liu, Qiang Zeng, Xin Zhao, Jian Dou, Jinglin Cao. Endocrine disrupting chemicals: A promoter of non-alcoholic fatty liver disease. Frontiers in Public Health 2023; 11 doi: 10.3389/fpubh.2023.1154837
213
Lihua Xiao, Hua Xiong, Zeyuan Deng, Xin Peng, Kejun Cheng, Hua Zhang, Li Jiang, Yong Sun. Tetrastigma hemsleyanumleaf extracts ameliorate NAFLD in mice with low-grade colitisviathe gut–liver axis. Food & Function 2023; 14(1) doi: 10.1039/D2FO03028D
214
Martina Montagnana, Elisa Danese, Sara Bonafini, Cristiano Fava. Childhood Obesity: A Multisystem Challenge Linking Hypertension, NAFLD, and Sleep Apnea. Medical Sciences 2026; 14(1) doi: 10.3390/medsci14010070
215
Serena Scapaticci, Ebe D’Adamo, Angelika Mohn, Francesco Chiarelli, Cosimo Giannini. Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin Resistance and Type 2 Diabetes. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.639548
216
Hyo Lim Lee, Jong Min Kim, Min Ji Go, Han Su Lee, Ju Hui Kim, In Young Kim, Geum-Su Seong, Ho Jin Heo. Fermented Protaetia brevitarsis Larvae Alleviates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in C57BL/6 Mice via Regulation of Lipid Accumulation and Inflammation. Journal of Microbiology and Biotechnology 2025; 35 doi: 10.4014/jmb.2409.09025
217
Yangyue Ni, Mengwen Huang, Shiyang Chen, Shihui Wang, Jianfeng Chen. Integrins and NAFLD-associated liver diseases: clinical associations, pathophysiological mechanisms and pharmacological implications. Acta Biochimica et Biophysica Sinica 2024; 56(11) doi: 10.3724/abbs.2024149
218
Nuria Barbarroja, Miriam Ruiz-Ponce, Laura Cuesta-López, Carlos Pérez-Sánchez, Chary López-Pedrera, Iván Arias-de la Rosa, Eduardo Collantes-Estévez. Nonalcoholic fatty liver disease in inflammatory arthritis: Relationship with cardiovascular risk. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.997270
219
Jing Qi, Jong-Won Kim, Zixiong Zhou, Chae-Woong Lim, Bumseok Kim. Ferroptosis Affects the Progression of Nonalcoholic Steatohepatitis via the Modulation of Lipid Peroxidation–Mediated Cell Death in Mice. The American Journal of Pathology 2020; 190(1) doi: 10.1016/j.ajpath.2019.09.011
220
Marcello Dallio, Mario Romeo, Antonietta Gerarda Gravina, Mario Masarone, Tiziana Larussa, Ludovico Abenavoli, Marcello Persico, Carmelina Loguercio, Alessandro Federico. Nutrigenomics and Nutrigenetics in Metabolic- (Dysfunction) Associated Fatty Liver Disease: Novel Insights and Future Perspectives. Nutrients 2021; 13(5) doi: 10.3390/nu13051679
221
Arnab Banerjee, Sandip Mukherjee, Bithin Kumar Maji. Worldwide flavor enhancer monosodium glutamate combined with high lipid diet provokes metabolic alterations and systemic anomalies: An overview. Toxicology Reports 2021; 8 doi: 10.1016/j.toxrep.2021.04.009
222
Mojtaba Rashidi, Reza Afarin, Maryam Kouchak, Benyamin Kabizadeh, Masoumeh Shamsi, Mahdi Hatami. Resveratrol and Saroglitazar: A Promising Combination for Targeting TGF-β/Smad3 Signaling and Attenuating Inflammatory Response in Nonalcoholic Steatohepatitis in Rats. Hepatitis Monthly 2023; 23(1) doi: 10.5812/hepatmon-138237
223
Lanshu Yang, Hongbing Ni, Meiling Deng, Tuo Guo, Jie Zhang, Baolan Sun, Weixia Yang. Elevated LECT2 and PEDF in Pediatric MAFLD: Diagnostic Performance and Metabolic Correlations. Diabetes, Metabolic Syndrome and Obesity 2025;  doi: 10.2147/DMSO.S555108
224
Haiyan Zhou, Maeda Toshiyoshi,, Wenli Zhao, Ye Zhao, Yan Zhao. Statins on nonalcoholic fatty liver disease: A systematic review and meta-analysis of 14 RCTs. Medicine 2023; 102(26) doi: 10.1097/MD.0000000000033981
225
Kyle Mahon, Mohammed Abo-Ismail, Emily Auten, Rodrigo Manjarin, Magdalena Maj. Transcriptomic Changes in the Frontal Cortex of Juvenile Pigs with Diet-Induced Metabolic Dysfunction-Associated Liver Disease. Biomedicines 2025; 13(7) doi: 10.3390/biomedicines13071567
226
Hui Du, Jihan Huang, Youhua Wang, Chunyan Wang, Yiqun Wang, Luming Hou, Yali Li, Ying Li, Qianmin Su. Analyzing MASLD interventional clinical trial registration based on the ClinicalTrials.gov database. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-03732-2
227
Carolyn Vespoli, Anoop Mohamed Iqbal, Mohammad Nasser Kabbany, Kadakkal Radhakrishnan. Metabolic-Associated Fatty Liver Disease in Childhood and Adolescence. Endocrinology and Metabolism Clinics of North America 2023; 52(3) doi: 10.1016/j.ecl.2023.02.001
228
Yun Ji, Yuan Gao, Hong Chen, Yue Yin, Weizhen Zhang. Indole-3-Acetic Acid Alleviates Nonalcoholic Fatty Liver Disease in Mice via Attenuation of Hepatic Lipogenesis, and Oxidative and Inflammatory Stress. Nutrients 2019; 11(9) doi: 10.3390/nu11092062
229
Seyedeh Alia Moosavian, Thozhukat Sathyapalan, Tannaz Jamialahmadi, Amirhossein Sahebkar, Giuseppe Ciccarella. The Emerging Role of Nanomedicine in the Management of Nonalcoholic Fatty Liver Disease: A State-of-the-Art Review. Bioinorganic Chemistry and Applications 2021; 2021 doi: 10.1155/2021/4041415
230
Jianbin Zhang, Daixi Jiang, Shuangzhe Lin, Yuqing Cheng, Jiaxing Pan, Wenjin Ding, Yuanwen Chen, Jiangao Fan. Prolyl endopeptidase disruption reduces hepatic inflammation and oxidative stress in methionine-choline-deficient diet-induced steatohepatitis. Life Sciences 2021; 270 doi: 10.1016/j.lfs.2021.119131
231
Xiaoyu Sun, Na Ge, Qingqing Liang, Qian Wang, Hui Yu, Min Jin. Effect of the total flavonoids of Dracocephalum moldavica L. on metabolic associated fatty liver disease in rats. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1549515
232
Liping Chen, Enhe Liu, Xi Zhao, Xiao Liu, Qin Dong, Yinpei Lou, Guoying Huang, Ling Li, Yuxin He. Scutellaria baicalensis Georgi in metabolic-associated fatty liver disease treatment: research progress. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1565461
233
Rasoul Akbari, Tahereh Behdarvand, Reza Afarin, Hamid Yaghooti, Mohammad Taha Jalali, Narges Mohammadtaghvaei. Saroglitazar improved hepatic steatosis and fibrosis by modulating inflammatory cytokines and adiponectin in an animal model of non-alcoholic steatohepatitis. BMC Pharmacology and Toxicology 2021; 22(1) doi: 10.1186/s40360-021-00524-8
234
Xiaoli Pan, Yanqiao Zhang. Hepatocyte nuclear factor 4α in the pathogenesis of non-alcoholic fatty liver disease. Chinese Medical Journal 2022; 135(10) doi: 10.1097/CM9.0000000000002092
235
Abdulrahman Ismaiel, Daniel-Corneliu Leucuta, Stefan-Lucian Popa, Dan L. Dumitrascu. Serum Visfatin Levels in Nonalcoholic Fatty Liver Disease and Liver Fibrosis: Systematic Review and Meta-Analysis. Journal of Clinical Medicine 2021; 10(14) doi: 10.3390/jcm10143029
236
Zhongyi Zhang, Yunliang He, Mei Zhao, Xin He, Zubing Zhou, Yuanyuan Yue, Tao Shen, Juncheng Liu, Gan Zhang, Yong Zhang. Qinlian Hongqu Decoction Modulates FXR/TGR5/GLP-1 Pathway to Improve Insulin Resistance in NAFLD Mice: Bioinformatics and Experimental Study. ACS Omega 2024; 9(45) doi: 10.1021/acsomega.4c07463
237
Jacob Beiriger, Kashyap Chauhan, Adnan Khan, Taha Shahzad, Natalia Salinas Parra, Peter Zhang, Sarah Chen, Anh Nguyen, Brian Yan, John Bruckbauer, Dina Halegoua-DeMarzio. Advancements in Understanding and Treating NAFLD: A Comprehensive Review of Metabolic-Associated Fatty Liver Disease and Emerging Therapies. Livers 2023; 3(4) doi: 10.3390/livers3040042
238
Qing Tao, Jing Xie, Yongkang Wu, Yong Jin. Long non-coding RNAs as modulators and therapeutic targets in non-alcoholic fatty liver disease (NAFLD). Gastroenterología y Hepatología (English Edition) 2024; 47(5) doi: 10.1016/j.gastre.2024.04.025
239
Devaraj Ezhilarasan. Unraveling the pathophysiologic role of galectin‐3 in chronically injured liver. Journal of Cellular Physiology 2023; 238(4) doi: 10.1002/jcp.30956
240
Feng Gao, Manyu Chen, Jianfeng Yu, Lu Xu, Lisha Yu, Honglin Jiang, Zhiliang Gu. Tetrahydrocurcumin protects against nonalcoholic fatty liver disease by improving lipid metabolism and redox homeostasis. Journal of Functional Foods 2022; 89 doi: 10.1016/j.jff.2022.104957
241
Ali KIRIK, Cemal Nuri ERCİN, Hasan GÜREL, Ali Fuat ÇİÇEK, Ali Cem YEKDEŞ, Sultan TÜREL, Serkan TAPAN, Teoman DOĞRU. The relationship of serum bilirubin level with histopathological parameters in patients with nonalcoholic fatty liver disease. DAHUDER Medical Journal 2023; 3(3) doi: 10.56016/dahudermj.1326075
242
Dieter Furthner, Christian-Heinz Anderwald, Peter Bergsten, Anders Forslund, Joel Kullberg, Håkan Ahlström, Hannes Manell, Iris Ciba, Harald Mangge, Katharina Maruszczak, Pia Koren, Sebastian Schütz, Susanne Maria Brunner, Anna Maria Schneider, Daniel Weghuber, Katharina Mörwald. Single Point Insulin Sensitivity Estimator in Pediatric Non-Alcoholic Fatty Liver Disease. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.830012
243
Hyunmi Kim, Da Som Lee, Tae Hyeon An, Hyun-Ju Park, Won Kon Kim, Kwang-Hee Bae, Kyoung-Jin Oh. Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC. International Journal of Molecular Sciences 2021; 22(9) doi: 10.3390/ijms22094495
244
Mi Hye Kim, Jung Bae Seong, Jae-Won Huh, Yong Chul Bae, Hyun-Shik Lee, Dong-Seok Lee. Peroxiredoxin 5 ameliorates obesity-induced non-alcoholic fatty liver disease through the regulation of oxidative stress and AMP-activated protein kinase signaling. Redox Biology 2020; 28 doi: 10.1016/j.redox.2019.101315
245
Jingyi Jin, Yue Li, Furong Qiu, Dongming Yan. Ferroptosis in metabolic dysfunction-associated steatotic liver disease: Molecular mechanisms and therapeutic potential of traditional Chinese medicine–a systematic review of preclinical studies. Pharmacological Research - Modern Chinese Medicine 2026; 20 doi: 10.1016/j.prmcm.2026.100857
246
Pawel E. Ferdek, Daria Krzysztofik, Kinga B. Stopa, Agnieszka A. Kusiak, Milena Paw, Dawid Wnuk, Monika A. Jakubowska. When healing turns into killing – the pathophysiology of pancreatic and hepatic fibrosis. The Journal of Physiology 2022; 600(11) doi: 10.1113/JP281135
247
Nayeon Kim, Sunyoon Jung, Eunjung Lee, Eun-Byeol Jo, Seongjun Yoon, Yoonhwa Jeong. Gryllus bimaculatus De Geer hydrolysates alleviate lipid accumulation, inflammation, and endoplasmic reticulum stress in palmitic acid-treated human hepatoma G2 cells. Journal of Ethnopharmacology 2022; 291 doi: 10.1016/j.jep.2022.115117
248
Hui Wu, Zi-Heng Zhang, Ting Ye, Jia-Ni Chen, Tao-Hsin Tung, Jian-Sheng Zhu. Efficacy and safety of GLP-1 receptor agonists in patients with metabolic-associated fatty liver diseases: an umbrella review. Frontiers in Medicine 2026; 13 doi: 10.3389/fmed.2026.1783429
249
Marina Konaktchieva, Radoslav Stojchevski, Nikola Hadzi-Petrushev, Hristo Gagov, Rositza Konakchieva, Vadim Mitrokhin, Gjoko Kungulovski, Mitko Mladenov, Dimiter Avtanski. Curcumin and Tetrahydrocurcumin as Multi-Organ Modulators of the Adipose Tissue–Gut–Liver Axis: Mechanistic Insights, Therapeutic Potential, and Translational Challenges. Pharmaceuticals 2025; 18(12) doi: 10.3390/ph18121791
250
Madhangi Parameswaran, Hamzah A Hasan, Jafor Sadeque, Sharan Jhaveri, Chaithanya Avanthika, Abimbola E Arisoyin, Maulik B Dhanani, Swaroopa M Rath . Factors That Predict the Progression of Non-alcoholic Fatty Liver Disease (NAFLD). Cureus 2021;  doi: 10.7759/cureus.20776
251
Maria Elena Capra, Brigida Stanyevic, Antonella Giudice, Delia Monopoli, Nicola Mattia Decarolis, Susanna Esposito, Giacomo Biasucci. Long-Chain Polyunsaturated Fatty Acids Effects on Cardiovascular Risk in Childhood: A Narrative Review. Nutrients 2023; 15(7) doi: 10.3390/nu15071661
252
Yue Li, Mengjia Lv, Meiling Shen, Xi Gu, Li Zhang, Xingyong Liu, Jing Chen, Likun Gong, Zhili Zuo. Identification of 3H-benzo[b] [1,4] diazepine derivatives as PPARα agonists by in silico studies and biochemical evaluation . Journal of Biomolecular Structure and Dynamics 2024; 42(19) doi: 10.1080/07391102.2023.2256867
253
Yohwan Lim, Seogsong Jeong, Myunghee Hong, Hyun Wook Han. Non-Alcoholic Fatty Liver Disease, Atherosclerosis, and Cardiovascular Disease in Asia. Reviews in Cardiovascular Medicine 2023; 24(6) doi: 10.31083/j.rcm2406173
254
Mirjana Macvanin, Milan Obradovic, Sonja Zafirovic, Julijana Stanimirovic, Esma R. Isenovic. The Role of miRNAs in Metabolic Diseases. Current Medicinal Chemistry 2023; 30(17) doi: 10.2174/0929867329666220801161536
255
Maria Felicia Faienza, Mariangela Chiarito, Emilio Molina-Molina, Harshitha Shanmugam, Frank Lammert, Marcin Krawczyk, Gabriele D’Amato, Piero Portincasa. Childhood obesity, cardiovascular and liver health: a growing epidemic with age. World Journal of Pediatrics 2020; 16(5) doi: 10.1007/s12519-020-00341-9
256
Richard E. Brown. Genetically modified mice for research on human diseases: A triumph for Biotechnology or a work in progress?. The EuroBiotech Journal 2022; 6(2) doi: 10.2478/ebtj-2022-0008
257
雯 郭. Research Progress of Porphyrin Metabolism in Fatty Liver Disease. Advances in Clinical Medicine 2024; 14(07) doi: 10.12677/acm.2024.1472017
258
Lizhi Liu, Danjing Chen, Shiyuan Wang, Wen Si, He Zhang, Yijun Jiang, Yongfeng Cai, Shanghua Xu, Xian-e Peng. Nonlinear associations of remnant cholesterol/high-density lipoprotein cholesterol ratio with the risk of metabolic-associated fatty liver disease: a cross-sectional study. BMC Gastroenterology 2026; 26(1) doi: 10.1186/s12876-026-04739-z
259
Shengying Gu, Shanshan Hu, Shuowen Wang, Chendong Qi, Chenyang Shi, Guorong Fan. Bidirectional association between NAFLD and gallstone disease: a systematic review and meta-analysis of observational studies. Expert Review of Gastroenterology & Hepatology 2023; 17(3) doi: 10.1080/17474124.2023.2175671
260
Jian-Wei Zhang, Hai-Tao Pan. microRNA profiles of serum exosomes derived from children with nonalcoholic fatty liver. Genes & Genomics 2022; 44(7) doi: 10.1007/s13258-021-01150-8
261
Junaura R. Barretto, Ney Boa-Sorte, Caian L. Vinhaes, Hayna Malta-Santos, Jessica Rebouças-Silva, Camila F. Ramos, Monica A. S. Torres-Nascimento, Valeria M. Borges, Bruno B. Andrade. Heightened Plasma Levels of Transforming Growth Factor Beta (TGF-β) and Increased Degree of Systemic Biochemical Perturbation Characterizes Hepatic Steatosis in Overweight Pediatric Patients: A Cross-Sectional Study. Nutrients 2020; 12(6) doi: 10.3390/nu12061650
262
Qing Tao, Jing Xie, Yongkang Wu, Yong Jin. Long non-coding RNAs as modulators and therapeutic targets in non-alcoholic fatty liver disease (NAFLD). Gastroenterología y Hepatología 2024; 47(5) doi: 10.1016/j.gastrohep.2023.09.014
263
Gowri Manohari Balachander, Inn Chuan Ng, Roopesh R. Pai, Kartik Mitra, Farah Tasnim, Yee Siang Lim, Royston Kwok, Yoohyun Song, Lai Ping Yaw, Clarissa Bernice Quah, Junzhe Zhao, Wahyunia L. Septiana, Vishnu Goutham Kota, Yao Teng, Kexiao Zheng, Yan Xu, Sei Hien Lim, Huck Hui Ng, Hanry Yu. LEADS – a comprehensive human liver-on-a-chip for non-alcoholic steatohepatitis (NASH) drug testing. Lab on a Chip 2025; 25(14) doi: 10.1039/D5LC00221D
264
Junfeng Wang, Hanxiang Wang, Xiawen Yang, Kaiping Wang, Yu Zhang. Recent advances in the role of polysaccharides in liver diseases: a review. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1535717
265
Hiroki Nishikawa, Soo Ki Kim, Sachiyo Yoshio, Akira Asai. Metabolic Dysfunction-Associated Steatotic Liver Disease and Sarcopenia: Review of Literature. Journal of Clinical Medicine 2026; 15(4) doi: 10.3390/jcm15041661
266
Mengfei Ning, Linfei Song, Xinyu Niu, Yiming Wang, Wenjie Liu, Jiaxiang Hu, Han Cai, Weitao Song, Long Liu, Huifang Li, Daoqing Gong, Jacqueline Smith, Yinhua Huang. Multiscale 3D genome organization underlies duck fatty liver with no adipose inflammation or serious injury. International Journal of Biological Macromolecules 2024; 271 doi: 10.1016/j.ijbiomac.2024.132452
267
ZhenYu Zhu, Ting Cao, Hui Chen, BiKui Zhang, ChenQuan Lin, HuaLin Cai. Olanzapine-induced nonalcoholic fatty liver disease: The effects of differential food pattern and the involvement of PGRMC1 signaling. Food and Chemical Toxicology 2023; 176 doi: 10.1016/j.fct.2023.113757
268
Ha-Neul Choi, Jin-Yeong Shin, Jung-In Kim. Ameliorative Effect of Myricetin on Nonalcoholic Fatty Liver Disease in ob/ob Mice. Journal of Medicinal Food 2021; 24(10) doi: 10.1089/jmf.2021.K.0090
269
Büşra Tetik Dinçer, Ayşe Merve Usta, Alev Kural, Nazlı Helvacı, Ahmet Uçar, Nafiye Urgancı. Can fecal calprotectin be used as a biomarker of non-alcoholic fatty liver disease in obese adolescents?. BMC Pediatrics 2024; 24(1) doi: 10.1186/s12887-024-05327-4
270
Mohammad SR Akhand, Sheikh M Noor-e-Alam, Mohammad A Rahim, Rezaul Karim, Rakibul Hasan, Debabrata Karmakar, Dipankar K Mondal, Nazia T Sopan, Jumana B Jalal, Mohammad A Arafat, Musarrat Mahtab, Sakirul Khan, Sheikh MF Akbar, Mamun Al Mahtab. Safety and Efficacy of Moringa oleifera Lam Supplementation in Patients with Metabolic Dysfunction-associated Steatotic Liver Disease: A Prospective Real-world Study from Bangladesh. Journal of Indian System of Medicine 2026; 14(3) doi: 10.5005/jism-11051-0050
271
Qingyan Ye, Yun Jiang, Di Wu, Jingwen Cai, Zhitian Jiang, Zhen Zhou, Liyan Liu, Qihua Ling, Qian Wang, Gang Zhao. Atractylodin alleviates nonalcoholic fatty liver disease by regulating Nrf2-mediated ferroptosis. Heliyon 2023; 9(7) doi: 10.1016/j.heliyon.2023.e18321
272
Melisa Kozaczek, Byungwhi Kong, Walter Bottje, Reza Hakkak. Hepatic Proteomics Analysis of Nonalcoholic Fatty Liver Disease Obese Rat Model After Short- and Long-Term Soy Protein Isolate Feeding. Journal of Medicinal Food 2022; 25(3) doi: 10.1089/jmf.2021.0088
273
Ping Li, Jianran Hu, Hongmei Zhao, Jing Feng, Baofeng Chai. Multi-Omics Reveals Inhibitory Effect of Baicalein on Non-Alcoholic Fatty Liver Disease in Mice. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.925349
274
Dongxin Yi, Ziyi Wu, Xiao Li, Bing Shao, Yuji Xiao, Tao Li, Xue Zhang, Jiaxin Zhu, Tao Yang, Yixue Deng, Tiecheng Huang, Tianming Qiu, Jie Bai, Xiaoxia Shi, Chenbing Wu, Zhiping Wu, Xiance Sun, Ningning Wang. Hydroxytyrosol Prevents Metabolic-Associated Steatohepatitis by Inhibiting SOCS2-Mediated Ferroptosis in High-Fat Diet Mice. Journal of Agricultural and Food Chemistry 2026; 74(7) doi: 10.1021/acs.jafc.5c16856
275
Tin Ei Cho, Ying Meng, Guoying Zhang, Jianya Ling. Cordyceps‐Fermented Chinese Jujube Ameliorates Oxidative Stress and Restores Gut Microbiome in Alcohol‐Induced Liver Injury in Mice. Molecular Nutrition & Food Research 2025; 69(22) doi: 10.1002/mnfr.70243
276
Yupeng Liu, Jingjing Song, Juan Yang, Jilin Zheng, Ling Yang, Jun Gao, Song Tian, Zhen Liu, Xiangbin Meng, Jian‐Cheng Wang, Zhifei Dai, Yi‐Da Tang. Tumor Necrosis Factor α–Induced Protein 8–Like 2 Alleviates Nonalcoholic Fatty Liver Disease Through Suppressing Transforming Growth Factor Beta–Activated Kinase 1 Activation. Hepatology 2021; 74(3) doi: 10.1002/hep.31832
277
Qinge Ma, Kejia Liu, Chenyu Chang, Lei Wang, Zhangyang Shen, Jiaxin Li, Mozili Adu, Qingyuan Lin, Huilian Huang, Xutao Wu, Rongrui Wei. Metabolic dysfunction‑associated steatotic liver disease: Pathogenesis, model and treatment (Review). International Journal of Molecular Medicine 2025; 56(6) doi: 10.3892/ijmm.2025.5668
278
Victoria L. Slaughter, John W. Rumsey, Rachel Boone, Duaa Malik, Yunqing Cai, Narasimhan Narasimhan Sriram, Christopher J. Long, Christopher W. McAleer, Stephen Lambert, Michael L. Shuler, J. J. Hickman. Validation of an adipose-liver human-on-a-chip model of NAFLD for preclinical therapeutic efficacy evaluation. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-92264-2
279
Xing Yan, Linnan Li, Pei Liu, Jie Xu, Zhengtao Wang, Lili Ding, Li Yang. . 2021;  doi: 10.2139/ssrn.3954272
280
Feng-Zhi Xin, Ze-Hua Zhao, Rui-Nan Zhang, Qin Pan, Zi-Zhen Gong, Chao Sun, Jian-Gao Fan. Folic acid attenuates high-fat diet-induced steatohepatitis <i>via</i> deacetylase SIRT1-dependent restoration of PPARα. World Journal of Gastroenterology 2020; 26(18): 2203-2220 doi: 10.3748/wjg.v26.i18.2203
281
Zhen Yang, Zhiwei Xiong, Qiuguo Wang, Ning Zhou. A bibliometric analysis of macrophages associated with non-alcoholic fatty liver disease research from 2005 to 2023. Heliyon 2024; 10(2) doi: 10.1016/j.heliyon.2024.e24187
282
Qiuyu Jiang, Jiale Li, Shengdi Wu, Li Zhang, Ling Dong, Shuqiang Weng, Wenqing Tang, She Chen. Enterococcus faecalis impairs IGSF9-dependent C1q degradation to accelerate MAFLD-HCC progression . Gut Microbes Reports 2026; 3(1) doi: 10.1080/29933935.2025.2600896
283
Ilaria Demori, Elena Grasselli. The Role of the Stress Response in Metabolic Dysfunction-Associated Fatty Liver Disease: A Psychoneuroendocrineimmunology-Based Perspective. Nutrients 2023; 15(3) doi: 10.3390/nu15030795
284
Antonella Mosca, Giuseppe Maggiore. Malattia grassa del fegato: tra fattori ambientali e predisposizione genetica. Medico e Bambino 2023; 42(6) doi: 10.53126/MEB42355
285
Hee-Kyoung Son, Bok-Hee Kim, Jisu Lee, Seohyun Park, Chung-Bae Oh, Sunyoon Jung, Jennifer K. Lee, Jung-Heun Ha. Partial Replacement of Dietary Fat with Krill Oil or Coconut Oil Alleviates Dyslipidemia by Partly Modulating Lipid Metabolism in Lipopolysaccharide-Injected Rats on a High-Fat Diet. International Journal of Environmental Research and Public Health 2022; 19(2) doi: 10.3390/ijerph19020843
286
Xinhe Zhang, Lin Guan, Haoyu Tian, Zilu Zeng, Jiayu Chen, Die Huang, Ji Sun, Jiaqi Guo, Huipeng Cui, Yiling Li. Risk Factors and Prevention of Viral Hepatitis-Related Hepatocellular Carcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.686962
287
Zheng Yang, Daoqing Gong, Xinxiang He, Fei Huang, Yi Sun, Qinming Hu. Association between daidzein intake and metabolic associated fatty liver disease: A cross-sectional study from NHANES 2017–2018. Frontiers in Nutrition 2023; 10 doi: 10.3389/fnut.2023.1113789
288
Hammad Ahmed, Muhammad Ihtisham Umar, Salman Imran, Faraza Javaid, Shahzada Khurram Syed, Romana Riaz, Waseem Hassan. TGF-β1 signaling can worsen NAFLD with liver fibrosis backdrop. Experimental and Molecular Pathology 2022; 124 doi: 10.1016/j.yexmp.2021.104733
289
Zhuoyu Li, Mengyao Zhao, Xiaoguo Ji, Liqiang Fan, Liming Zhao. Alginate oligosaccharides improve high-fat induced hepatic steatosis via PGC-1α-mediated lipophagy and fatty acid β-oxidation pathway. Journal of Functional Foods 2023; 110 doi: 10.1016/j.jff.2023.105825
290
Mioara Desdemona Stepan, Ștefănița Bianca Vintilescu, Ioana Streață, Mihaela Andreea Podeanu, Dan Nicolae Florescu. The Role of Vitamin D in Obese Children with Non-Alcoholic Fatty Liver Disease and Associated Metabolic Syndrome. Nutrients 2023; 15(9) doi: 10.3390/nu15092113
291
Shujuan Guo, Juan Zheng, Guimei Li. Effects of growth hormone on lipid metabolism and sexual development in pubertal obese male rats. Open Life Sciences 2022; 17(1) doi: 10.1515/biol-2022-0515
292
Hasen A. Al-ghamdi, Fayza F. Al Fayez, Abdulhadi I. Bima, Taghreed M. Khawaji, Ayman Z. Elsamanoudy. Study of Cellular Senescence and Vitamin D Deficiency in Nonalcoholic Fatty Liver Disease and The Potential Protective Effect of Vitamin D Supplementation. Journal of Clinical and Experimental Hepatology 2021; 11(2) doi: 10.1016/j.jceh.2020.07.003
293
Hao Yang, Lijuan Zhang, Xinle Tang. Integrated Network Pharmacology and Gut Microbiota Analysis Reveals the Alcoholic Extract of Anacyclus pyrethrum Root Prevents Nonalcoholic Fatty Liver Disease via the LPS/TLR4/NF-κB Pathway. International Journal of Molecular Sciences 2026; 27(10) doi: 10.3390/ijms27104398
294
Z. Yang, P. Li, Q. Shang, Y. Wang, J. He, S. Ge, R. Jia, X. Fan. CRISPR-mediated BMP9 ablation promotes liver steatosis via the down-regulation of PPARα expression. Science Advances 2020; 6(48) doi: 10.1126/sciadv.abc5022
295
Fang Yao, Gaochao Wang, Fan Ning, Yanbo Shi. Targeting Ferroptosis: New Insights and Therapeutic Advances in MAFLD Complicating T2DM. Frontiers in Bioscience-Landmark 2025; 30(10) doi: 10.31083/FBL39735
296
Tao Zhang, Yingli Nie, Jiliang Wang. The emerging significance of mitochondrial targeted strategies in NAFLD treatment. Life Sciences 2023; 329 doi: 10.1016/j.lfs.2023.121943
297
Dong-fang Fu, Bin Chen. The relationship between the systemic immune inflammation index and the nonalcoholic fatty liver disease in American adolescents. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03324-6
298
Guoliang Yin, Hongyi Liang, Wenxiu Sun, Shizhao Zhang, Yanan Feng, Pengpeng Liang, Suwen Chen, Xiangyi Liu, Wenchao Pan, Fengxia Zhang. Shuangyu Tiaozhi decoction alleviates non-alcoholic fatty liver disease by improving lipid deposition, insulin resistance, and inflammation in vitro and in vivo. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1016745
299
Matthew C. Sinton, David C. Hay, Amanda J. Drake. Metabolic control of gene transcription in non-alcoholic fatty liver disease: the role of the epigenome. Clinical Epigenetics 2019; 11(1) doi: 10.1186/s13148-019-0702-5
300
Jin Hwa Kim, Young Sang Lyu, Mee Kyoung Kim, Sang Yong Kim, Ki‐Hyun Baek, Ki‐Ho Song, Kyungdo Han, Hyuk‐Sang Kwon. Repeated detection of non‐alcoholic fatty liver disease increases the incidence risk of type 2 diabetes in young adults. Diabetes, Obesity and Metabolism 2024; 26(1) doi: 10.1111/dom.15304
301
翠愿 郭. Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease: Correlation and Management. Advances in Clinical Medicine 2024; 14(08) doi: 10.12677/acm.2024.1482257
302
Shumin Wei, Xiaoying Yu. Efficacy of resveratrol supplementation on liver enzymes in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis. Complementary Therapies in Medicine 2021; 57 doi: 10.1016/j.ctim.2020.102635
303
Waleed Alghamdi, Mahmoud Mosli, Saleh A. Alqahtani. Gut microbiota in MAFLD: therapeutic and diagnostic implications. Therapeutic Advances in Endocrinology and Metabolism 2024; 15 doi: 10.1177/20420188241242937
304
Yin-Zhao Jia, Qiao-Juan Mei, Yong Zhang. MiR-484 participates in non-alcoholic fatty liver injury by targeting SIRT1 to mediate cell apoptosis. World Chinese Journal of Digestology 2021; 29(8) doi: 10.11569/wcjd.v29.i8.389
305
Lide Arenaza, María Medrano, Maddi Oses, Maria Amasene, Ignacio Díez, Beatriz Rodríguez-Vigil, Idoia Labayen. The Effect of a Family-Based Lifestyle Education Program on Dietary Habits, Hepatic Fat and Adiposity Markers in 8–12-Year-Old Children with Overweight/Obesity. Nutrients 2020; 12(5) doi: 10.3390/nu12051443
306
Shouxing Yang, Jinwei Zhong, Mengsi Ye, Lei Miao, Guangrong Lu, Changlong Xu, Zhanxiong Xue, Xinhe Zhou. Association between the non-HDL-cholesterol to HDL-cholesterol ratio and non-alcoholic fatty liver disease in Chinese children and adolescents: a large single-center cross-sectional study. Lipids in Health and Disease 2020; 19(1) doi: 10.1186/s12944-020-01421-5
307
Juana Carretero-Gómez, Francisco Javier Carrasco-Sánchez, José María Fernández-Rodríguez, Pedro Casado-Escribano, José Pablo Miramontes-González, José Miguel Seguí-Ripoll, Javier Ena, José Carlos Arévalo-Lorido. Effect of semaglutide on fatty liver disease biomarkers in patients with diabetes and obesity. Revista Clínica Española (English Edition) 2023; 223(3) doi: 10.1016/j.rceng.2022.12.001
308
Panli Tan, Li Jin, Xiang Qin, Beihui He. Natural flavonoids: Potential therapeutic strategies for non-alcoholic fatty liver disease. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1005312
309
Dhadhang Wahyu Kurniawan, Gert Storm, Jai Prakash, Ruchi Bansal. Role of spleen tyrosine kinase in liver diseases. World Journal of Gastroenterology 2020; 26(10): 1005-1019 doi: 10.3748/wjg.v26.i10.1005
310
Tianyang Huang, Yahui Liu, Huiming Li, Ying Zhang, Dezhi Kong, Guozhen Cui. β‐Glucan ameliorates nonalcoholic steatohepatitis induced by methionine and choline‐deficient diet in mice. Journal of Food Biochemistry 2020; 44(10) doi: 10.1111/jfbc.13408
311
Li-Hong He, Dun-Han Yao, Ling-Yun Wang, Lei Zhang, Xue-Li Bai. Gut Microbiome-Mediated Alteration of Immunity, Inflammation, and Metabolism Involved in the Regulation of Non-alcoholic Fatty Liver Disease. Frontiers in Microbiology 2021; 12 doi: 10.3389/fmicb.2021.761836
312
Averie Dickinson, Amreen Dinani, Kara Wegermann. Chemoprevention of hepatocellular carcinoma associated with metabolic dysfunction-associated steatotic liver disease: an updated review. Hepatoma Research 2024;  doi: 10.20517/2394-5079.2024.81
313
Yu-Tsung Chou, Chung-Hao Li, Zih-Jie Sun, Wei-Chen Shen, Yi-Ching Yang, Feng-Hwa Lu, Chih-Jen Chang, Jin-Shang Wu. A Positive Relationship between Betel Nut Chewing and Significant Liver Fibrosis in NAFLD Subjects, but Not in Non-NAFLD Ones. Nutrients 2021; 13(3) doi: 10.3390/nu13030914
314
Marina V. Maevskaya, Yulia V. Kotovskaya, Vladimir T. Ivashkin, Olga N. Tkacheva, Ekaterina A. Troshina, Marina V. Shestakova, Valeriy V. Breder, Natalia I. Geyvandova, Vladimir L. Doshchitsin, Ekaterina N. Dudinskaya, Ekaterina V. Ershova, Khava B. Kodzoeva, Ksenia A. Komshilova, Natalia V. Korochanskaya, Alexander Yu. Mayorov, Ekaterina E. Mishina, Maria Yu. Nadinskaya, Igor G. Nikitin, Nana V. Pogosova, Aida I. Tarzimanova, Minara Sh. Shamkhalova. The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities. Terapevticheskii arkhiv 2022; 94(2) doi: 10.26442/00403660.2022.02.201363
315
Yigui Zou, Yu Dai, Hu Chen, Ziyuan Li, Baixian Lin, Zeling Zhuang, Wenwen Li, Qinghua Yang, Dongling Dai. MAFLD outperforms NAFLD in identifying metabolic dysfunction in U.S. adolescents: a NHANES 2017–2020 analysis. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-04170-w
316
Jingyuan Xu, Hongyang Tian, Yajun Ji, Lei Dong, Yandong Liu, Yatao Wang, Xuefen Gao, Haitao Shi, Hong Li, Longbao Yang. Urolithin C reveals anti-NAFLD potential via AMPK-ferroptosis axis and modulating gut microbiota. Naunyn-Schmiedeberg's Archives of Pharmacology 2023; 396(10) doi: 10.1007/s00210-023-02492-8
317
Jingwei Li, Ruixian Chen, Jinhang Zhang, Jinhan He, Yuxi Wang, Yanping Li. Targeting THR-β for MASLD Treatment: Current Progression and Emerging Prospects. Journal of Medicinal Chemistry 2026; 69(2) doi: 10.1021/acs.jmedchem.5c03114
318
Livhuwani P. Nendouvhada, Nicole R. S. Sibuyi, Adewale O. Fadaka, Samantha Meyer, Abram M. Madiehe, Mervin Meyer, Kwazikwakhe B. Gabuza. Phytonanotherapy for the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease. International Journal of Molecular Sciences 2024; 25(11) doi: 10.3390/ijms25115571
319
Xutao Li, Tianyin Ruan, Siyuan Wang, Mingyue Li, Li Shen, Yuan Peng, Zhimin Zhao, Yang Lei, Yanyan Tao. Compound Dancao Granules inhibits lipid accumulation and hepatocyte apoptosis via the p53 signaling pathway in metabolic dysfunction-associated steatohepatitis mice. Journal of Ethnopharmacology 2026; 368 doi: 10.1016/j.jep.2026.121779
320
Shuhui Nie, Xiaoyu Qian, You Zhao, Ting Yao, Winfrida William Munyonyela, Huan Zhang, Menyuan Hu, Shengdong Wu, Guangliang Wu, Ping Chen, Liyun Fu. STING signaling in liver diseases and the therapeutic potential of nanodrug delivery systems. Genes & Diseases 2026;  doi: 10.1016/j.gendis.2026.102453
321
Yinhua Ni, Liyang Ni, Fen Zhuge, Zhengwei Fu. The Gut Microbiota and Its Metabolites, Novel Targets for Treating and Preventing Non‐Alcoholic Fatty Liver Disease. Molecular Nutrition & Food Research 2020; 64(17) doi: 10.1002/mnfr.202000375
322
Igor V Maev, Aleksey A Samsonov, Liudmila K Palgova, Chavdar S Pavlov, Elena I Vovk, Elena N Shirokova, Kirill M Starostin. Effectiveness of phosphatidylcholine in alleviating steatosis in patients with non-alcoholic fatty liver disease and cardiometabolic comorbidities (MANPOWER study). BMJ Open Gastroenterology 2020; 7(1) doi: 10.1136/bmjgast-2019-000341
323
Xiaoyu Wang, GuangBing Li, Jun Liu, Wei Gong, Ruixiao Li, Jun Liu. GSK621 ameliorates lipid accumulation via AMPK pathways and reduces oxidative stress in hepatocytes in vitro and in obese mice in vivo. Life Sciences 2025; 374 doi: 10.1016/j.lfs.2025.123687
324
Hai-Xin Chen, Fan Yang, Xin-Qian He, Ting Li, Yong-Zhi Sun, Jian-Ping Song, Xin-An Huang, Wen-Feng Guo. Garcinia Biflavonoid 1 Improves Lipid Metabolism in HepG2 Cells via Regulating PPARα. Molecules 2022; 27(6) doi: 10.3390/molecules27061978
325
Emmanouil Koullias, Maria Papavdi, John Koskinas, Melanie Deutsch, Anastasia Thanopoulou. Targeting Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Available and Future Pharmaceutical Options. Cureus 2025;  doi: 10.7759/cureus.76716
326
Melisa Kozaczek, Walter Bottje, Diyana Albataineh, Reza Hakkak. Effects of Short- and Long-Term Soy Protein Feeding on Hepatic Cytochrome P450 Expression in Obese Nonalcoholic Fatty Liver Disease Rat Model. Frontiers in Nutrition 2021; 8 doi: 10.3389/fnut.2021.699620
327
Jiali Zhang, Baochen Ma, Zixu Wang, Yaoxing Chen, Chengzhong Li, Yulan Dong. Extracellular vesicle therapy for obesity-induced NAFLD: a comprehensive review of current evidence. Cell Communication and Signaling 2024; 22(1) doi: 10.1186/s12964-023-01292-0
328
Yan Jiang, Narazah Mohd Yusoff, Jiang Du, Emmanuel Jairaj Moses, Jun-Tang Lin. Current perspectives on mesenchymal stem cells as a potential therapeutic strategy for non-alcoholic fatty liver disease. World Journal of Stem Cells 2024; 16(7): 760-772 doi: 10.4252/wjsc.v16.i7.760
329
Stephanie Wissel, Hubert Scharnagl, Marcus E. Kleber, Graciela Delgado, Angela Moissl, Bernhard Krämer, Winfried März. Fatty liver-index, systemic inflammation and cardiovascular mortality. Results from the LURIC study. Atherosclerosis 2025; 411 doi: 10.1016/j.atherosclerosis.2025.120557
330
Hatice Merve Bayram, Fuzail Mohammed Majoo, Arda Ozturkcan. Polyphenols in the prevention and treatment of non-alcoholic fatty liver disease: An update of preclinical and clinical studies. Clinical Nutrition ESPEN 2021; 44 doi: 10.1016/j.clnesp.2021.06.026
331
Noha M. Hany, Sanaa Eissa, Manal Basyouni, Amany H. Hasanin, Yasmin M. Aboul-Ela, Nagwa M. Abo Elmagd, Iman F. Montasser, Mahmoud A. Ali, Paul J. Skipp, Marwa Matboli. Modulation of hepatic stellate cells by Mutaflor® probiotic in non-alcoholic fatty liver disease management. Journal of Translational Medicine 2022; 20(1) doi: 10.1186/s12967-022-03543-z
332
Xu Chen, Xiaoyuan Sun, Tianran Shen, Qian Chen, Shen Chen, Juan Pang, Jiaxin Mi, Yi Tang, Yiran You, Huihui Xu, Wenhua Ling. Lower adropin expression is associated with oxidative stress and severity of nonalcoholic fatty liver disease. Free Radical Biology and Medicine 2020; 160 doi: 10.1016/j.freeradbiomed.2020.08.005
333
Hyun-Jung Park, SunYoung Lee, Minsook Ye, Bong Hee Han, Hyun Soo Shim, Daehyuk Jang, Insop Shim. Anti-Obesity Effect of Chitoglucan in High-Fat-Induced Obesity Mice. International Journal of Environmental Research and Public Health 2022; 20(1) doi: 10.3390/ijerph20010281
334
Pathak Indrani, Sen Susruta, Karmakar Minakshi, Bhattacharjee Nivedita, Choudhuri Sharmistha. A Cross-Sectional Analysis of The Use of Different Ratios Of Hepatic Enzymes As Potential Markers For Non-Alcoholic Steatotic Hepatitis (NASH). Journal of Applied Biochemistry & Laboratory Medicine 2024; 5(1) doi: 10.5005/JABLM-11031-05104
335
F. Meng, L. Pian, Q. Wang, J. Chen, Y. Liu, J. Zhao. Ultrasound-guided attenuation parameter: a liver fat quantification technique for forecasting the progression of metabolic dysfunction-associated steatotic liver disease in overweight/obese patients. Clinical Radiology 2025; 84 doi: 10.1016/j.crad.2025.106854
336
Michele Walsh, Deborah John, Nicole Peritore, Andrea Morris, Carolyn Bird, Marion Ceraso, Sarah Eichberger, Rachel Novotny, Laura Stephenson, Suzanne Stluka, Roberta Riportella. Health in All Policies: Working Across Sectors in Cooperative Extension to Promote Health for All. Journal of Human Sciences and Extension 2018;  doi: 10.54718/RYTE6013
337
Chengan Xu, Shouhao Wang, Di Meng, Mingshan Wang, Rong Yan, Yining Dai. Neuregulin1 ameliorates metabolic dysfunction-associated fatty liver disease via the ERK/SIRT1 signaling pathways. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-03632-5
338
Rong Yang, Lian Feng, Zhijian Gong, Huili Yang, Haiyan Du, Jing Chen, Meirong Qin, Ning Chen, Houshuang Huang, Ping Wang, Qibiao Wu, Yufeng Xing. Shugan Xiaozhi Decoction attenuates nonalcoholic steatohepatitis by modulating oxidative stress and AMPK pathway. BMC Complementary Medicine and Therapies 2025; 25(1) doi: 10.1186/s12906-025-05099-z
339
Xinhe Zhang, Haoyu Tian, Yiling Li. The pathophysiological mechanism between hypopituitarism and nonalcoholic fatty liver disease. iLIVER 2022; 1(1) doi: 10.1016/j.iliver.2022.02.004
340
Chance S. Friesen, Chelsea Hosey-Cojocari, Sherwin S. Chan, Iván L. Csanaky, Jonathan B. Wagner, Brooke R. Sweeney, Alec Friesen, Jason D. Fraser, Valentina Shakhnovich. Efficacy of Weight Reduction on Pediatric Nonalcoholic Fatty Liver Disease: Opportunities to Improve Treatment Outcomes Through Pharmacotherapy. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.663351
341
Hailing Peng, Yumin Qing, Liu Han, Shifeng Fu, Jianglei Li, Siyi Wang, Deliang Liu, Lini Liu, Yuyong Tan. Effect of Antidepressants on Non-alcoholic Fatty Liver Disease and their Underlying Mechanism. Current Medicinal Chemistry 2025; 32(35) doi: 10.2174/0109298673317281240828170031
342
Hager H. Shaaban, Ibrahim Alzaim, Ahmed El-Mallah, Rania G. Aly, Ahmed F. El-Yazbi, Ahmed Wahid. Metformin, pioglitazone, dapagliflozin and their combinations ameliorate manifestations associated with NAFLD in rats via anti-inflammatory, anti-fibrotic, anti-oxidant and anti-apoptotic mechanisms. Life Sciences 2022; 308 doi: 10.1016/j.lfs.2022.120956
343
Thomas Pixner, Nathalie Stummer, Anna Maria Schneider, Andreas Lukas, Karin Gramlinger, Valérie Julian, David Thivel, Katharina Mörwald, Katharina Maruszczak, Harald Mangge, Julian Gomahr, Daniel Weghuber, Dieter Furthner. The Role of Macronutrients in the Pathogenesis, Prevention and Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) in the Paediatric Population—A Review. Life 2022; 12(6) doi: 10.3390/life12060839
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.